rfhg_238715.1

Basic information about the TSS

---

TSS ID: rfhg_238715.1 Species: human Chr: chrX		Start: 119574876 End: 119574906 Strand: +
Source datasets	PRJNA401781|PRJNA615891|PRJNA597322
Protocol	CAGE|RAMPAGE|SLIC_CAGE|STRIPE-seq
TSS cluster detected*	4

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4306727,EH38E2766217)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000628549.1:-128 GeneID: 7319 HGNC/MGI_ID: HGNC:12472 UniProt_ID: A0A0D9SG71 Nearer transcript ids and distances: AB590387:-165 DQ893386:-165 DQ896706:-165 KJ904582:-165 M74524:-284 ENST00000629303.2:-298 BC010175:-302 ENST00000469205.2:-305 AK223064:-308 AK297696:-311 AK223045:-311 ENST00000371558.7:-313 ENST00000630695.2:-313 ENST00000631185.2:-313 NM_001282161.2:-313 NM_181762.3:-313 NM_003336.4:-313 AK313092:-313 ENST00000625379.1:-327 ENST00000625938.2:-330 D28459:-338 ENST00000346330.6:-340 AK301675:-341 view more...

Gene_name: ubiquitin conjugating enzyme E2 A Gene_symbol: UBE2A Gene_synonyms: HHR6A HR6A RAD6A UBC2 Gene_source: HGNC:12472

TATA-Box annotation

---

Distance to TSS:	328
Nearest PromoterID:	NM_001282161
Entrez ID:	7319
Nearest Unigene:	Hs.379466
Nearest Refseq:	NM_003336
Nearest Ensembl:	ENSG00000077721
Gene Name:	ubiquitin conjugating enzyme E2 A
Gene Alias:	HHR6A|MRXS30|MRXSN|RAD6A|UBC2
Gene Type:	protein-coding
CpG%:	0.033333
GC%:	0.612903
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UBE2A p2@UBE2A p3@UBE2A p4@UBE2A
Sample		p1@UBE2A	p2@UBE2A	p3@UBE2A	p4@UBE2A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	129.15	6.23	0.58	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	130.90	5.87	0.20	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	152.39	7.33	0.77	1.74
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	137.84	5.61	0.21	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	142.85	6.52	1.12	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	153.89	4.26	0.39	1.55
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	157.53	6.54	0.22	3.70
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	135.40	7.51	0.48	2.18
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	111.77	9.40	1.07	2.56
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	143.75	3.48	1.16	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	111.97	6.06	0.40	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	126.44	2.85	0.81	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	26.76	3.87	3.87	2.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	31.72	5.11	5.41	2.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	25.69	5.27	6.81	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	25.90	3.52	3.27	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	20.53	3.49	4.80	1.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	23.20	2.11	4.22	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	26.12	3.20	4.80	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	27.23	3.91	4.96	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	24.99	4.01	5.88	1.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	30.21	3.80	5.01	2.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	28.44	4.39	4.39	2.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	25.48	3.15	3.15	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	28.89	4.64	4.39	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	23.42	2.85	4.75	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	25.28	4.95	2.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	31.59	3.54	5.19	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	32.63	3.39	5.33	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	27.51	3.08	4.34	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	28.05	4.81	5.44	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	32.04	4.69	4.30	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	39.46	4.64	5.49	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	43.21	6.93	8.91	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	28.42	5.24	4.49	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	31.62	4.22	4.41	2.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	32.29	4.29	4.91	2.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	30.42	4.84	4.84	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	37.27	5.13	7.02	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	36.73	2.64	7.68	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	34.35	3.76	5.88	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	42.31	6.44	6.88	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	34.80	4.43	4.01	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	36.71	5.24	5.42	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	32.53	6.22	5.62	2.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	24.20	4.65	5.58	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	37.43	4.56	3.12	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	34.57	3.58	7.45	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	33.99	4.31	3.59	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	32.96	4.25	4.65	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	38.94	4.30	6.35	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	36.47	5.34	6.00	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	31.94	6.74	5.32	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	37.12	7.29	5.30	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	83.05	12.58	10.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	49.60	5.97	7.81	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	41.49	7.45	4.54	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	35.33	5.14	5.14	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	47.46	5.03	7.86	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	39.48	7.05	0.71	3.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	36.45	3.93	3.36	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	62.90	7.17	3.98	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	32.96	7.14	5.10	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	33.47	6.82	3.57	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	28.40	6.39	2.48	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	94.77	7.90	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	35.10	7.31	1.46	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	38.18	7.44	1.49	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	39.87	5.63	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	44.38	8.28	3.97	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	37.12	8.04	2.78	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	39.14	5.20	1.53	2.75
Adipocyte - breast, donor1	11376-118A8	79.98	9.19	4.59	2.06
Adipocyte - breast, donor2	11327-117E4	81.66	8.34	2.41	2.89
Adipocyte - omental, donor1	11473-119C6	87.91	7.12	3.31	2.54
Adipocyte - omental, donor2	11474-119C7	63.54	6.73	3.74	2.99
Adipocyte - omental, donor3	11475-119C8	54.59	9.71	1.67	2.01
Adipocyte - perirenal, donor1	11476-119C9	61.89	5.74	3.83	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	43.98	4.40	1.10	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	59.61	6.32	2.71	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	60.30	6.60	2.61	2.43
Adipocyte differentiation, day04, donor1	13019-139D4	50.46	10.95	2.35	2.35
Adipocyte differentiation, day04, donor2	13022-139D7	50.19	6.43	3.35	2.57
Adipocyte differentiation, day04, donor3	13025-139E1	63.00	8.92	2.23	2.23
Adipocyte differentiation, day04, donor4	13028-139E4	64.07	11.17	2.35	4.70
Adipocyte differentiation, day08, donor1	13020-139D5	106.65	9.65	3.46	4.10
Adipocyte differentiation, day08, donor2	13023-139D8	64.55	10.33	2.26	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	55.45	7.46	1.60	2.67
Adipocyte differentiation, day08, donor4	13029-139E5	63.43	9.46	1.11	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	108.13	7.49	4.16	5.41
Adipocyte differentiation, day12, donor2	13024-139D9	67.31	7.28	2.76	4.02
Adipocyte differentiation, day12, donor3	13027-139E3	82.47	7.53	1.64	3.93
Adipocyte differentiation, day12, donor4	13030-139E6	76.73	7.92	1.83	4.26
Alveolar Epithelial Cells, donor1	11510-119G7	104.31	12.38	1.10	1.77
Alveolar Epithelial Cells, donor2	11590-120G6	60.24	11.47	0.72	2.51
Alveolar Epithelial Cells, donor3	11671-122G6	34.74	8.39	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	69.26	10.79	1.08	2.70
Amniotic Epithelial Cells, donor2	11613-122A2	45.18	5.02	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	62.25	6.37	1.23	2.05
Anulus Pulposus Cell, donor1	11248-116E6	61.90	9.04	7.32	2.63
Anulus Pulposus Cell, donor2	11463-119B5	48.74	8.57	2.20	2.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	73.68	5.84	2.70	2.70
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	95.08	9.99	5.21	3.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	57.79	10.70	6.42	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	82.20	7.77	4.48	3.89
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	79.67	5.06	5.06	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	45.54	5.28	4.62	3.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	79.27	5.85	2.92	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	89.32	6.80	4.85	3.40
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	54.04	4.75	2.97	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	86.25	4.90	6.03	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	85.63	9.43	5.08	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	55.17	11.28	3.76	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	78.25	7.91	6.92	1.98
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	102.36	4.09	1.36	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	51.12	5.28	2.41	1.96
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	91.62	8.57	4.29	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	72.17	7.37	4.72	2.08
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	55.06	9.62	1.60	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	105.35	7.80	2.93	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	64.69	5.81	3.32	2.49
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	55.23	4.80	2.40	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	63.72	7.08	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	67.41	7.03	2.92	2.23
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	37.75	8.39	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	84.46	5.83	5.34	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	77.03	7.97	1.90	3.04
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	69.05	6.06	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	87.79	8.55	5.13	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	67.13	7.70	3.85	2.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	54.72	5.42	4.13	2.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	88.21	4.22	0.94	2.82
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	65.60	7.07	2.57	2.25
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	51.37	7.13	2.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	82.48	5.85	3.51	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	66.54	8.73	4.22	1.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	51.08	7.13	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	93.07	9.15	5.59	6.10
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	66.73	9.68	2.80	3.06
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	57.18	3.81	3.18	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	83.72	3.45	4.75	3.02
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	64.56	7.41	2.75	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	51.04	5.80	1.74	3.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	92.58	9.45	3.78	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	64.25	9.15	2.20	1.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	55.59	4.63	4.63	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	118.30	4.23	10.56	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	66.68	7.29	3.65	2.14
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	56.56	3.61	3.61	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	105.70	8.02	5.10	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	68.50	7.82	3.45	3.22
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	63.76	12.75	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	63.30	5.08	4.58	3.56
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	72.25	5.16	4.13	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	61.20	5.20	4.59	3.06
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	88.91	9.56	1.91	4.30
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	66.74	6.21	2.66	2.66
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	54.93	10.68	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	61.48	9.42	1.66	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	64.08	6.62	2.38	2.65
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	59.24	4.72	4.00	2.18
Astrocyte - cerebellum, donor1	11500-119F6	89.66	12.53	2.70	1.97
Astrocyte - cerebellum, donor2	11580-120F5	64.36	9.58	1.71	2.05
Astrocyte - cerebellum, donor3	11661-122F5	52.23	10.49	0.84	3.15
Astrocyte - cerebral cortex, donor1	11235-116D2	79.48	7.67	2.44	3.14
Astrocyte - cerebral cortex, donor2	11316-117D2	84.93	9.87	1.94	3.72
Astrocyte - cerebral cortex, donor3	11392-118C6	72.79	9.70	0.75	2.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	80.39	11.58	1.49	4.01
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	89.33	9.77	0.63	2.76
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	74.31	8.53	1.02	3.98
Basophils, donor1	12241-129G9	74.01	10.20	1.05	3.66
Basophils, donor2	12242-129H1	95.25	10.46	0.72	2.53
Basophils, donor3	12243-129H2	70.85	9.70	1.03	2.79
Bronchial Epithelial Cell, donor1	11511-119G8	64.03	10.78	1.51	3.67
Bronchial Epithelial Cell, donor2	11591-120G7	34.75	3.66	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	7.17	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	40.80	8.79	0.00	2.51
Bronchial Epithelial Cell, donor5	11457-119A8	41.17	6.03	0.21	1.46
Bronchial Epithelial Cell, donor6	11461-119B3	36.16	6.45	0.69	1.38
Bronchial Epithelial Cell, donor7	11769-123I5	55.96	13.68	2.70	3.42
Burkitt's lymphoma cell line:DAUDI	10422-106C8	135.31	7.21	4.74	0.72
Burkitt's lymphoma cell line:RAJI	10476-106I8	113.89	6.99	2.56	2.56
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	76.43	6.72	11.51	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	134.45	0.00	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	55.23	10.14	3.38	2.25
CD14+ Monocytes, donor2	11305-117B9	67.37	7.80	0.74	4.45
CD14+ Monocytes, donor3	11381-118B4	54.01	9.44	0.88	1.98
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	60.01	5.38	1.70	1.98
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	54.59	10.99	1.14	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	63.45	10.85	3.62	1.97
CD14+ monocytes - mock treated, donor1	11863-125A9	124.17	12.14	1.30	4.34
CD14+ monocytes - mock treated, donor2	11873-125C1	97.46	10.56	1.51	2.72
CD14+ monocytes - mock treated, donor3	11883-125D2	107.79	15.63	2.13	4.26
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	118.85	10.38	0.84	4.35
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	109.30	8.00	1.10	4.69
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	120.00	13.88	1.98	2.98
CD14+ monocytes - treated with BCG, donor1	11860-125A6	109.65	12.14	1.37	3.33
CD14+ monocytes - treated with BCG, donor2	11870-125B7	88.49	10.33	0.89	4.63
CD14+ monocytes - treated with BCG, donor3	11880-125C8	152.99	19.59	2.83	3.26
CD14+ monocytes - treated with Candida, donor1	11868-125B5	100.67	9.83	1.64	3.98
CD14+ monocytes - treated with Candida, donor2	11878-125C6	93.99	14.26	2.64	3.70
CD14+ monocytes - treated with Candida, donor3	11888-125D7	114.26	15.53	1.11	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	105.17	13.09	2.08	2.68
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	111.15	11.17	2.39	2.39
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	156.36	14.37	2.50	3.96
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	133.61	14.64	1.37	3.43
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	120.34	11.99	2.26	4.30
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	118.28	10.48	1.31	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	112.98	15.87	1.34	3.77
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	113.22	10.47	2.44	4.36
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	127.51	13.47	1.68	3.37
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	128.60	14.15	0.55	2.94
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	114.84	13.03	0.35	3.17
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	131.18	10.97	1.75	2.63
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	107.07	8.37	0.35	4.01
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	91.43	13.38	1.49	4.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	146.14	15.09	2.80	3.02
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	90.50	13.92	2.46	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	116.13	11.13	2.55	2.78
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	144.76	11.14	2.09	4.64
CD14+CD16+ Monocytes, donor1	11789-124B7	80.86	11.99	0.87	2.83
CD14+CD16+ Monocytes, donor2	11801-124D1	90.78	11.32	0.00	3.70
CD14+CD16+ Monocytes, donor3	11912-125G4	77.33	13.86	0.43	4.33
CD14+CD16- Monocytes, donor1	11788-124B6	86.27	13.08	1.25	4.20
CD14+CD16- Monocytes, donor2	11799-124C8	70.56	11.53	1.22	4.37
CD14+CD16- Monocytes, donor3	11910-125G2	86.73	13.82	1.11	5.57
CD14-CD16+ Monocytes, donor1	11790-124B8	99.52	12.25	0.51	4.34
CD14-CD16+ Monocytes, donor2	11800-124C9	91.56	12.08	0.88	1.76
CD14-CD16+ Monocytes, donor3	11911-125G3	96.85	12.21	0.63	5.26
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	87.39	4.06	2.03	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	71.87	7.46	1.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	105.63	14.50	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	100.21	7.46	0.53	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	86.84	8.04	0.00	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	84.93	10.53	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	76.87	7.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	122.60	3.95	0.00	2.64
CD19+ B Cells, donor1	11544-120B5	90.41	7.40	0.82	2.47
CD19+ B Cells, donor2	11624-122B4	89.23	2.90	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	71.69	7.07	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	159.20	19.80	4.44	5.66
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	103.87	18.38	2.00	2.40
CD34+ Progenitors, donor1	11545-120B6	45.18	6.02	6.02	1.00
CD34+ Progenitors, donor2	11625-122B5	90.45	10.11	7.87	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	78.16	6.76	10.15	4.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	96.96	8.34	10.15	3.16
CD4+ T Cells, donor1	11225-116C1	87.12	6.78	0.71	0.71
CD4+ T Cells, donor2	11306-117C1	83.89	9.80	0.00	2.45
CD4+ T Cells, donor3	11382-118B5	77.77	7.01	0.00	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	71.98	10.46	0.26	3.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	62.66	9.43	0.00	3.14
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	55.19	9.20	0.29	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	69.69	3.79	0.47	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	57.59	4.21	0.70	2.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	6.59	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	74.14	9.39	0.58	2.31
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	73.72	7.96	0.51	2.54
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	53.52	7.25	0.64	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	80.25	6.28	0.00	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	74.07	7.34	0.35	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	83.16	10.12	0.00	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	69.15	16.02	0.42	2.95
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	54.64	9.56	0.00	4.99
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	51.46	9.36	0.67	4.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	54.39	6.80	0.27	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	55.74	9.65	1.07	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	32.28	5.38	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	104.58	15.95	0.74	3.15
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	81.23	9.10	0.43	3.47
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	83.85	9.46	0.42	3.15
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	69.27	9.61	0.00	4.04
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	77.99	5.20	0.43	3.47
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	67.99	10.02	0.44	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	68.29	11.38	0.49	3.46
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	84.93	10.16	0.00	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	67.00	5.58	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	75.05	5.82	1.11	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	74.35	11.53	0.49	1.96
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	80.08	20.02	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	73.41	11.46	0.36	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	63.71	5.54	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	122.45	5.89	0.00	0.98
CD8+ T Cells, donor2	11307-117C2	113.76	6.76	0.75	0.75
CD8+ T Cells, donor3	11383-118B6	80.29	7.32	0.76	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	61.48	4.82	0.92	2.29
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	63.03	5.75	0.72	3.12
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	63.75	4.65	0.82	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	85.56	8.71	1.80	2.70
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	76.07	6.00	0.72	3.84
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	74.13	5.68	0.91	2.50
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	62.14	8.04	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	64.48	7.63	0.79	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	68.01	5.16	0.47	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	80.00	6.64	0.00	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	77.86	8.13	0.87	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	74.87	7.19	0.80	3.73
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	69.60	3.50	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	77.88	7.29	0.00	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	63.40	5.97	0.00	5.97
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	62.31	7.92	1.08	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	67.33	5.47	0.29	2.59
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	61.05	4.48	0.24	2.59
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	72.57	6.65	0.32	3.17
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	67.05	7.69	0.62	1.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	48.41	9.30	0.32	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	68.46	6.12	0.76	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	67.79	5.52	0.39	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	69.59	11.35	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	97.16	9.64	0.00	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	106.31	7.69	2.80	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	107.19	10.02	1.00	2.00
Cardiac Myocyte, donor1	11525-119I4	58.49	9.14	1.83	5.48
Cardiac Myocyte, donor2	11605-120I3	48.42	6.92	0.99	2.96
Cardiac Myocyte, donor3	11686-122I3	59.88	9.05	3.26	2.10
Chondrocyte - de diff, donor1	11261-116G1	105.73	10.40	4.16	2.77
Chondrocyte - de diff, donor2	11338-117F6	52.60	6.75	3.20	2.49
Chondrocyte - de diff, donor3	11410-118E6	70.77	9.67	5.12	4.55
Chondrocyte - re diff, donor2	11339-117F7	118.17	11.64	15.22	1.79
Chondrocyte - re diff, donor3	11411-118E7	43.68	6.07	4.85	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	75.97	7.57	3.67	1.49
Ciliary Epithelial Cells, donor2	11323-117D9	64.56	8.55	2.57	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	60.62	6.90	1.24	1.95
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	55.02	10.27	4.49	5.41
Corneal Epithelial Cells, donor1	11526-119I5	55.77	11.64	0.66	4.39
Corneal Epithelial Cells, donor2	11606-120I4	76.22	12.51	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	64.93	11.25	0.77	3.32
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	60.09	5.78	1.16	3.47
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	64.66	6.31	1.26	4.10
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	86.27	0.00	3.45	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	52.05	7.88	1.62	3.24
Dendritic Cells - plasmacytoid, donor1	11228-116C4	99.42	5.47	2.73	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	107.72	7.18	1.96	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	111.79	6.78	3.39	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	71.21	7.34	0.83	2.17
Endothelial Cells - Aortic, donor1	11263-116G3	58.09	4.69	0.59	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	66.74	8.48	1.13	1.98
Endothelial Cells - Aortic, donor3	11412-118E8	55.44	7.86	0.79	1.97
Endothelial Cells - Artery, donor1	11264-116G4	76.21	10.76	0.87	3.49
Endothelial Cells - Artery, donor2	11341-117F9	86.11	10.59	0.24	3.53
Endothelial Cells - Artery, donor3	11413-118E9	66.44	7.19	0.53	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	67.38	7.76	1.77	3.77
Endothelial Cells - Lymphatic, donor2	11317-117D3	65.72	9.74	2.43	2.43
Endothelial Cells - Lymphatic, donor3	11393-118C7	69.07	10.43	1.41	2.54
Endothelial Cells - Microvascular, donor1	11265-116G5	71.61	8.02	1.49	2.08
Endothelial Cells - Microvascular, donor2	11342-117G1	55.19	7.81	1.56	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	47.36	8.51	1.56	3.40
Endothelial Cells - Thoracic, donor1	11266-116G6	109.23	12.00	1.60	4.40
Endothelial Cells - Thoracic, donor2	11343-117G2	73.90	6.29	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	96.91	10.81	1.62	3.60
Endothelial Cells - Umbilical vein, donor2	11324-117E1	57.14	9.34	0.87	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	70.71	7.82	0.61	1.59
Endothelial Cells - Vein, donor1	11267-116G7	39.81	7.96	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	51.69	4.89	1.40	2.10
Endothelial Cells - Vein, donor3	11416-118F3	53.07	6.28	0.47	1.26
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	262.39	36.31	1.65	18.15
Eosinophils, donor3	12246-129H5	192.61	42.80	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	54.00	7.82	0.49	2.44
Esophageal Epithelial Cells, donor2	11587-120G3	87.37	14.56	2.08	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	78.41	4.93	4.11	2.46
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	56.50	5.91	3.83	2.08
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	59.26	7.58	3.90	2.71
Fibroblast - Aortic Adventitial, donor1	11245-116E3	89.50	6.67	2.91	2.30
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	71.92	7.64	2.46	2.18
Fibroblast - Aortic Adventitial, donor2	11326-117E3	68.66	9.91	3.48	2.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	36.89	8.17	1.58	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	77.07	7.64	2.99	1.99
Fibroblast - Cardiac, donor1	11268-116G8	70.77	9.98	2.72	0.45
Fibroblast - Cardiac, donor2	11345-117G4	62.91	12.13	2.27	1.52
Fibroblast - Cardiac, donor3	11417-118F4	64.03	4.57	2.21	2.21
Fibroblast - Cardiac, donor4	11452-119A3	68.50	7.27	4.85	2.42
Fibroblast - Cardiac, donor5	11456-119A7	62.06	6.85	1.40	2.54
Fibroblast - Cardiac, donor6	11460-119B2	61.70	7.43	0.30	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	110.27	11.66	2.41	1.47
Fibroblast - Choroid Plexus, donor2	11572-120E6	74.21	4.75	2.59	3.88
Fibroblast - Choroid Plexus, donor3	11653-122E6	71.77	14.65	1.46	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	91.56	10.84	2.77	2.77
Fibroblast - Conjunctival, donor3	11692-122I9	81.24	9.50	10.52	4.07
Fibroblast - Dermal, donor1	11269-116G9	47.66	7.98	2.35	1.41
Fibroblast - Dermal, donor2	11346-117G5	75.00	10.38	1.89	2.36
Fibroblast - Dermal, donor3	11418-118F5	50.41	8.22	3.51	3.02
Fibroblast - Dermal, donor4	11450-119A1	49.63	7.23	1.36	1.92
Fibroblast - Dermal, donor5	11454-119A5	61.93	7.68	1.22	1.74
Fibroblast - Dermal, donor6	11458-119A9	66.43	8.77	0.65	1.95
Fibroblast - Gingival, donor1	11237-116D4	67.26	8.54	1.87	2.71
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	76.50	9.43	6.29	4.72
Fibroblast - Gingival, donor2	11318-117D4	68.92	9.62	3.03	2.50
Fibroblast - Gingival, donor3	11394-118C8	65.94	11.89	3.48	2.80
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	93.50	13.51	8.31	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	85.63	10.22	2.82	4.93
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	123.78	9.98	5.30	3.12
Fibroblast - Gingival, donor6 (control)	11922-125H5	105.48	9.06	4.87	3.25
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	59.64	6.35	3.53	3.53
Fibroblast - Gingival, donor7 (control)	11924-125H7	108.37	10.68	5.41	2.63
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	104.17	9.27	4.50	3.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	118.80	8.99	3.07	3.73
Fibroblast - Gingival, donor9 (control)	11927-125I1	88.34	11.74	7.92	4.11
Fibroblast - Lung, donor1	11270-116H1	33.98	2.72	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	59.69	8.95	1.49	4.48
Fibroblast - Lung, donor3	11419-118F6	57.82	9.07	1.90	2.32
Fibroblast - Lymphatic, donor1	11506-119G3	109.13	12.50	2.50	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	58.74	9.79	1.40	4.20
Fibroblast - Lymphatic, donor3	11667-122G2	52.06	4.76	1.40	1.96
Fibroblast - Mammary, donor1	11540-120B1	116.92	13.40	0.81	4.47
Fibroblast - Mammary, donor2	11620-122A9	55.92	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	53.61	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	65.95	7.76	2.91	3.10
Fibroblast - Periodontal Ligament, donor2	11319-117D5	78.27	9.71	1.82	3.03
Fibroblast - Periodontal Ligament, donor3	11395-118C9	106.79	8.87	4.28	4.59
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	93.50	10.69	3.43	2.67
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	93.42	9.99	4.05	2.43
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	69.82	11.02	3.60	3.83
Fibroblast - Pulmonary Artery, donor1	11250-116E8	88.87	7.85	1.88	2.76
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	131.26	13.82	2.84	1.42
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	64.15	10.02	1.34	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	56.54	7.51	2.37	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	73.23	6.55	1.98	2.58
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	67.67	9.06	7.28	2.13
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	81.20	12.42	8.67	3.74
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	61.98	8.72	1.50	2.71
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	92.30	11.66	5.61	2.59
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	65.29	9.62	4.56	2.28
Fibroblast - skin normal, donor1	11553-120C5	82.70	10.01	5.91	2.46
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	69.78	5.81	0.80	2.41
Fibroblast - skin normal, donor2	11561-120D4	116.13	11.15	3.82	3.21
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	76.16	9.67	2.72	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	84.17	9.20	7.46	2.57
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	91.63	10.26	12.14	1.88
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	72.58	7.23	2.30	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	126.76	10.76	5.75	2.77
Fibroblast - skin walker warburg, donor1	11554-120C6	88.89	10.96	4.05	2.53
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	91.27	11.60	8.94	3.29
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	88.64	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	54.91	12.20	2.61	4.36
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	105.40	9.36	3.12	3.47
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	98.89	10.41	1.56	3.38
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	97.35	11.50	0.51	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	67.37	5.36	3.83	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	71.46	7.66	5.10	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	63.90	9.13	2.28	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	49.64	7.45	7.17	2.48
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	30.60	8.90	7.08	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	58.65	7.73	4.56	2.58
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	47.32	7.14	6.87	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	29.68	3.26	7.18	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	63.24	8.84	4.86	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	54.69	7.07	6.92	2.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	61.94	6.28	5.30	2.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	56.14	7.52	3.76	2.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	76.94	6.44	2.11	4.71
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	78.90	7.61	2.63	3.60
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	58.96	8.34	3.25	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	57.04	6.62	1.60	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	62.03	7.10	1.99	1.99
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	58.58	7.43	3.06	2.62
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	60.57	7.09	2.07	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	60.88	7.15	2.23	2.23
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	46.92	8.71	1.56	2.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	52.83	7.66	1.61	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	62.09	6.62	2.54	2.88
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	76.44	6.38	2.13	1.95
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	60.35	6.87	3.54	3.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	53.45	10.59	3.93	1.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	57.65	6.09	3.54	2.43
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	63.89	5.99	2.91	2.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	62.28	5.92	2.45	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	54.26	7.22	1.86	2.06
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	48.65	4.50	2.88	2.77
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	58.37	5.84	0.67	1.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	47.61	7.72	2.20	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	60.51	7.13	4.18	2.21
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	53.98	6.81	2.59	2.11
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	48.11	7.06	4.81	3.53
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	44.53	5.59	1.14	2.18
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	43.81	4.90	1.11	1.58
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	60.21	5.78	3.04	2.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	57.08	6.17	1.99	2.20
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	42.37	5.27	2.20	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	60.88	10.38	2.81	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	49.53	5.65	1.02	2.04
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	56.42	7.22	1.34	2.14
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	65.95	7.19	1.53	2.14
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	68.27	6.09	1.17	2.33
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	53.67	7.05	2.44	2.71
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	61.57	10.69	1.84	2.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	59.87	9.21	1.54	2.19
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	69.42	10.91	3.97	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	70.18	9.37	1.85	2.24
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	57.90	9.08	3.23	1.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	97.85	14.23	5.34	3.81
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	84.60	9.16	9.16	1.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	58.39	7.86	8.63	2.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	82.86	11.46	6.14	3.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	77.61	9.70	5.01	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	74.59	9.61	2.83	2.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	59.03	5.07	2.77	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	66.82	12.37	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	90.51	10.44	2.32	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	83.43	9.63	6.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	76.51	5.22	5.22	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	73.23	9.11	3.91	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	63.83	8.65	2.06	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	3.33	0.00	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	68.51	6.71	1.68	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	80.40	9.48	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	64.59	4.19	2.52	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	61.39	7.32	4.13	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	73.71	9.85	3.40	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	52.20	6.26	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	71.59	6.87	3.44	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	55.64	7.10	3.85	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	49.13	5.08	6.78	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	84.08	7.46	3.73	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	73.41	6.67	4.14	1.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	79.03	0.00	15.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	58.43	5.38	5.77	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	58.67	4.24	4.24	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	54.84	6.02	3.34	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	55.48	5.78	8.86	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	92.77	7.19	6.85	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	57.15	2.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	48.60	8.49	5.66	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	57.33	3.62	5.43	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	60.02	8.65	9.66	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	54.24	4.79	3.59	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	58.71	5.43	4.44	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	49.58	5.90	2.36	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	47.26	8.75	5.25	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	48.28	6.58	4.39	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	41.54	5.09	5.09	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	48.35	5.97	5.37	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	50.95	2.91	5.34	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	47.93	9.13	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	55.72	7.48	2.08	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	93.33	10.12	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	61.53	12.05	4.76	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	53.47	9.19	3.76	2.92
Hep-2 cells mock treated, biol_rep1	11898-125E8	128.57	17.52	2.67	5.92
Hep-2 cells mock treated, biol_rep2	11899-125E9	133.35	20.26	2.87	6.08
Hep-2 cells mock treated, biol_rep3	11900-125F1	117.62	16.38	1.37	6.60
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	124.28	16.07	3.61	6.45
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	125.29	16.33	4.30	5.80
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	105.70	14.42	3.44	7.53
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	135.75	18.81	2.24	6.73
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	121.11	16.13	3.60	3.95
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	115.97	16.98	1.92	4.49
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	67.15	7.83	0.00	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	63.62	8.22	0.43	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	66.10	5.29	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	83.24	7.76	2.12	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	67.57	3.63	0.73	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	73.08	6.82	2.27	2.10
Hepatocyte, donor1	11523-119I2	41.16	9.68	1.21	1.21
Hepatocyte, donor2	11603-120I1	74.34	11.85	1.08	2.15
Hepatocyte, donor3	11684-122I1	32.52	7.98	0.00	4.91
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	112.91	5.22	1.31	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	76.90	6.12	5.42	2.10
Iris Pigment Epithelial Cells, donor1	11530-119I9	57.08	5.49	1.10	2.33
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	63.68	6.37	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	13.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	59.53	9.69	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	77.58	12.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	35.60	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	64.07	25.63	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	59.42	4.57	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	64.97	14.62	0.00	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	66.69	13.34	1.67	8.34
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	50.83	7.26	7.26	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	64.85	25.15	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	57.65	17.74	2.22	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	52.38	15.71	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	52.28	2.52	1.26	3.15
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	57.23	4.64	1.55	6.19
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	71.71	7.11	0.65	5.17
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	59.57	11.27	0.00	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	57.86	12.22	1.63	4.07
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	61.71	8.40	1.26	4.20
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	66.71	9.64	4.02	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	52.63	14.77	0.92	3.69
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	69.39	11.33	2.36	2.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	59.86	9.07	1.81	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	88.45	14.74	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	71.02	8.61	1.08	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	55.90	15.25	0.00	5.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	72.70	9.57	0.00	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	63.79	12.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	68.55	5.71	2.14	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	43.14	16.59	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	58.95	9.26	2.47	2.78
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	59.70	10.54	0.00	7.02
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	59.72	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	70.23	9.04	0.70	3.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	50.90	8.85	4.43	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	84.29	9.73	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	52.32	8.72	2.62	8.72
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	78.74	15.75	0.00	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	45.30	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	56.54	12.80	1.07	4.27
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	49.88	11.08	1.39	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	39.89	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	68.11	12.89	0.00	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	39.33	0.00	3.03	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	18.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	51.81	8.46	4.23	1.06
Keratinocyte - epidermal, donor1	11272-116H3	88.54	9.30	0.82	3.26
Keratinocyte - epidermal, donor2	11349-117G8	45.68	7.61	2.34	2.34
Keratinocyte - epidermal, donor3	11421-118F8	75.16	10.60	0.76	2.93
Keratinocyte - oral, donor1	11251-116E9	69.36	15.67	3.86	8.06
Keratocytes, donor1	11527-119I6	128.94	9.97	4.81	4.13
Keratocytes, donor2	11607-120I5	75.00	7.03	1.17	0.00
Keratocytes, donor3	11688-122I5	53.75	7.51	2.57	3.36
Krukenberg tumor cell line:HSKTC	10687-109F3	134.07	21.98	8.79	2.20
Lens Epithelial Cells, donor1	11529-119I8	69.04	7.55	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	64.36	10.03	4.61	2.08
Lens Epithelial Cells, donor3	11690-122I7	86.88	9.99	3.13	1.72
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	56.32	9.49	1.07	2.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	45.77	6.70	0.56	1.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	56.98	7.71	1.10	2.83
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	51.62	7.53	1.08	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	48.85	6.30	0.63	3.78
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	47.01	6.47	0.86	2.91
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	48.43	8.21	0.82	2.87
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	43.48	9.61	1.52	5.06
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	44.48	7.04	1.27	1.69
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	60.91	10.28	0.79	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	56.42	7.56	0.97	2.71
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	33.51	5.92	0.37	2.04
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	58.19	12.19	1.05	2.09
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	49.61	5.72	1.43	2.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	44.36	7.00	1.51	1.79
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	57.90	14.17	1.85	2.16
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	44.58	4.36	0.62	2.49
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	41.90	8.05	2.01	2.38
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	59.90	8.89	0.99	2.63
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	37.49	4.69	0.59	2.34
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	44.31	6.47	0.25	1.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	55.77	7.76	0.97	3.88
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	50.90	8.35	0.81	2.96
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	48.29	10.60	1.21	2.57
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	54.43	10.89	2.07	4.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	57.16	8.79	0.42	3.77
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	48.72	8.72	0.75	2.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	73.60	12.38	2.06	4.82
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	59.83	9.78	1.51	1.51
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	47.50	8.69	1.80	1.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	62.51	5.33	1.94	2.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	46.97	7.94	1.32	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	50.30	7.68	0.87	2.35
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	61.83	9.26	1.48	2.59
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	52.88	6.42	1.48	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	48.81	6.46	0.69	2.20
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	59.82	8.36	1.93	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	65.43	9.13	0.91	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	58.79	7.00	1.26	2.94
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	57.60	8.89	1.78	2.13
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	65.93	10.18	1.45	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	41.55	6.54	0.31	1.09
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	57.65	6.09	0.72	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	70.89	9.47	1.96	2.29
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	39.55	6.36	0.47	1.88
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	72.64	8.17	1.49	2.60
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	53.53	5.12	1.28	1.54
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	48.04	4.48	1.19	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	81.58	13.60	9.06	6.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	73.64	10.74	6.14	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	51.96	14.84	8.16	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	63.47	9.73	7.62	3.39
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	54.16	9.85	7.74	7.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	63.51	12.14	7.47	4.67
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	49.98	6.70	10.31	6.18
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	45.20	14.27	11.89	5.95
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	54.06	10.18	9.27	3.39
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	66.89	10.76	9.60	5.82
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	66.18	16.66	10.80	4.50
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	72.21	10.57	8.67	4.74
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	72.92	13.87	6.68	3.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	64.57	13.41	6.00	9.17
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	58.63	9.33	9.99	6.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	63.16	10.70	10.70	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	73.64	11.47	10.94	5.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	73.12	11.34	8.88	5.48
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	62.58	16.57	10.43	4.91
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	77.47	10.60	4.89	7.34
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	68.93	11.45	8.54	5.41
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	64.18	15.13	6.73	3.36
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	46.37	21.64	5.15	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	74.90	16.26	5.52	4.06
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	68.16	11.36	7.47	3.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	59.20	14.94	8.85	3.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	71.05	13.79	6.72	4.95
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	68.22	14.01	9.59	3.69
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	61.02	14.97	12.66	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	67.16	15.35	7.29	5.37
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	59.44	4.53	9.62	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	56.61	18.87	9.03	5.74
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	60.10	13.56	4.97	4.97
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	68.94	9.34	8.62	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	76.93	15.68	2.99	6.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	66.89	12.26	5.20	4.46
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	56.86	14.21	6.46	3.02
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	52.23	13.70	6.85	4.28
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	72.30	11.66	10.00	6.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	80.84	17.50	7.84	4.22
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	73.94	12.80	5.69	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	57.40	11.69	7.91	3.78
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	77.83	9.12	6.98	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	69.36	18.18	8.08	8.75
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	68.90	17.41	6.30	4.82
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	79.08	17.44	5.81	3.49
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	61.35	19.04	6.35	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	67.63	10.00	5.60	6.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	53.06	11.63	7.27	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	68.99	19.16	9.96	6.13
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	68.57	12.33	7.89	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	63.98	16.94	6.59	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	72.91	11.06	9.05	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	64.89	11.72	9.46	6.31
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	60.24	18.93	3.44	15.49
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	68.58	16.03	6.23	3.56
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	57.09	11.73	7.43	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	60.70	13.19	9.24	3.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	69.02	19.20	8.30	4.15
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	60.82	16.19	7.44	3.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	67.09	8.39	8.95	3.91
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	67.57	13.69	8.39	6.62
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	78.30	16.59	8.10	4.24
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	62.79	17.72	5.57	7.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	77.86	12.02	8.17	3.84
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	64.00	12.72	7.95	3.98
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	77.17	12.76	4.86	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	65.71	9.68	8.30	6.23
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	61.94	12.16	8.36	4.56
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	65.58	12.39	6.71	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	75.58	13.91	9.67	3.63
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	66.87	11.41	7.29	6.34
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	58.64	14.39	3.73	3.73
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	64.94	9.77	5.17	5.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	58.11	18.51	6.69	3.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	60.83	10.61	9.20	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	69.23	12.48	9.65	3.97
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	68.64	9.15	5.41	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	81.44	14.88	6.26	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	68.06	10.02	7.52	4.59
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	68.30	10.69	3.25	4.65
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	78.28	12.71	2.68	5.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	68.43	10.69	7.48	3.21
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	69.91	11.31	4.85	4.85
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	67.00	7.34	9.18	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	92.47	8.89	7.11	5.33
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	73.51	17.67	6.27	3.99
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	67.49	13.04	6.14	5.37
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	74.96	12.04	7.11	5.47
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	76.17	17.37	7.13	4.01
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	94.10	15.08	7.28	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	92.17	17.90	13.26	7.29
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	58.20	14.55	12.47	6.24
Macrophage - monocyte derived, donor1	11232-116C8	54.93	7.75	0.68	3.19
Macrophage - monocyte derived, donor2	11313-117C8	48.08	9.18	0.92	2.75
Macrophage - monocyte derived, donor3	11389-118C3	59.77	7.47	1.31	3.67
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	113.64	12.21	1.59	1.06
Mallassez-derived cells, donor2	11929-125I3	126.44	14.89	1.74	3.01
Mallassez-derived cells, donor3	11930-125I4	141.35	14.18	2.36	2.08
Mammary Epithelial Cell, donor1	11273-116H4	87.89	10.36	4.38	3.29
Mammary Epithelial Cell, donor2	11350-117G9	72.97	13.61	2.90	3.76
Mammary Epithelial Cell, donor3	11422-118F9	50.63	5.24	1.00	2.49
Mast cell - stimulated, donor1	11487-119E2	119.99	21.02	2.03	2.03
Mast cell, donor1	11563-120D6	63.80	10.60	2.92	2.92
Mast cell, donor2	11565-120D8	54.38	8.62	7.73	4.46
Mast cell, donor3	11566-120D9	53.13	9.46	6.75	3.38
Mast cell, donor4	11567-120E1	48.93	7.62	3.37	3.19
Mast cell, expanded and stimulated, donor5	11940-126A5	67.42	15.75	1.77	4.44
Mast cell, expanded and stimulated, donor8	11942-126A7	58.95	9.34	2.33	2.33
Mast cell, expanded, donor5	11939-126A4	60.69	12.62	1.84	4.02
Mast cell, expanded, donor8	11941-126A6	54.39	9.54	1.34	2.68
Melanocyte - dark, donor1	11502-119F8	82.58	12.44	1.59	2.59
Melanocyte - dark, donor2	11582-120F7	51.91	3.11	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	85.77	8.91	2.75	2.32
Melanocyte - light, donor1	11274-116H5	38.08	5.88	1.41	1.41
Melanocyte - light, donor2	11351-117H1	40.27	1.36	1.36	0.68
Melanocyte - light, donor3	11423-118G1	35.56	3.47	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	53.31	7.60	1.56	1.87
Melanocyte, donor2 (MC+2)	12739-135I3	79.07	6.19	1.08	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	70.45	7.77	3.21	1.87
Meningeal Cells, donor1	11493-119E8	119.22	13.15	2.23	2.48
Meningeal Cells, donor2	11573-120E7	87.59	12.76	1.76	2.20
Meningeal Cells, donor3	11654-122E7	115.41	12.71	2.28	2.45
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	83.27	8.84	2.57	3.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	67.42	6.24	3.32	1.71
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	47.31	1.31	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	61.48	6.54	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	86.11	11.48	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	68.19	9.11	4.24	2.12
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	81.93	11.56	4.52	4.02
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	85.70	7.91	1.32	4.40
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	83.29	6.58	2.19	3.65
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	79.18	9.82	0.61	2.86
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	54.71	9.00	7.76	1.39
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	51.30	6.32	0.74	1.86
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	75.00	8.55	5.26	1.71
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	52.52	6.53	2.67	1.78
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	23.36	9.34	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	52.51	4.48	0.00	2.56
Mesenchymal stem cells - adipose, donor0	11217-116B2	101.37	10.63	0.35	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	63.48	9.38	2.81	2.19
Mesenchymal stem cells - umbilical, donor0	11214-116A8	54.43	5.81	1.45	3.63
Mesothelial Cells, donor1	11247-116E5	82.47	8.75	2.92	2.39
Mesothelial Cells, donor2	12156-128G5	103.60	9.01	4.50	3.50
Mesothelial Cells, donor3	11402-118D7	70.89	7.59	2.82	1.52
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	59.41	5.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	70.93	8.87	2.96	1.97
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	60.66	8.24	0.88	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	13.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	52.07	5.58	0.62	4.34
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	57.25	6.85	0.41	2.49
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	6.95	0.00	6.95
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	57.56	7.51	1.75	2.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	69.36	6.05	0.93	2.79
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	62.18	7.32	1.83	3.25
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	54.64	8.32	1.19	3.56
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	50.44	3.54	0.88	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	59.65	8.36	1.52	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	32.90	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	53.69	7.85	2.12	1.70
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	27.62	5.52	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	53.95	5.96	1.49	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	6.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	33.95
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	56.45	6.77	0.50	2.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	60.37	5.47	0.24	3.09
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	42.02	4.42	1.11	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	74.60	7.14	1.38	2.07
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	57.84	6.73	1.05	1.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	65.23	6.52	0.61	2.45
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	68.22	9.44	2.15	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	64.02	7.56	0.89	2.45
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	68.33	6.35	1.10	1.53
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	53.74	2.03	1.52	2.53
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	67.94	4.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	85.89	4.89	1.09	2.45
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	77.64	6.18	2.65	2.94
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	57.79	1.09	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	79.29	9.13	0.96	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	94.45	5.60	2.40	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	46.62	8.23	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	104.62	10.01	1.00	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	34.65	6.12	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	105.10	8.76	1.31	2.19
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	46.35	2.21	0.00	3.31
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	52.51	5.76	0.00	3.84
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	124.95	11.90	2.73	2.73
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	56.37	6.26	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	57.46	13.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	92.31	8.55	1.03	2.39
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	58.64	5.69	0.00	3.06
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	45.10	3.55	0.00	3.91
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	96.51	10.94	1.96	5.05
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	72.32	9.14	0.00	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	43.12	9.32	0.00	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	86.58	7.54	0.00	1.81
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	79.30	8.35	1.67	2.09
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	21.66	0.00	14.44
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	56.34	6.46	0.92	3.69
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	97.89	6.83	1.14	3.98
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	67.16	5.39	0.41	3.32
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	91.48	8.55	0.78	2.07
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	87.94	10.30	0.86	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	33.03	7.62	0.00	2.54
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	56.58	8.27	0.00	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	76.93	12.27	2.10	3.29
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	58.62	5.79	0.14	1.98
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	84.09	9.87	0.00	1.91
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	94.64	8.18	0.66	2.87
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	47.40	8.34	0.00	3.41
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	75.00	7.10	0.28	2.84
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	94.63	11.31	0.49	2.46
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	37.15	8.47	0.00	2.61
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	64.69	8.82	0.29	1.76
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	86.79	10.96	0.58	3.46
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	55.64	9.89	0.41	2.47
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	56.58	11.02	0.30	2.08
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	3.77	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	35.65	7.13	1.78	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	76.56	10.84	1.64	2.96
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	53.65	4.21	2.10	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	48.24	4.94	1.58	1.98
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	57.74	7.45	3.73	4.66
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	64.59	10.89	1.88	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	45.01	6.13	1.07	2.66
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	59.83	7.46	0.57	2.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	41.99	8.84	0.74	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	57.90	6.23	1.10	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	46.67	12.44	1.56	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	98.87	16.03	4.28	5.88
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	54.09	7.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	59.59	13.13	1.01	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	69.99	8.43	0.84	3.79
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	99.42	6.81	4.09	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	103.00	10.81	5.09	4.45
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	173.31	14.58	0.81	4.05
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	86.09	9.06	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	91.35	22.84	3.26	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	57.03	14.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	115.47	10.99	3.88	1.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	90.41	12.02	4.70	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	58.74	14.02	3.34	7.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	42.99	5.01	0.00	2.50
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	76.25	11.41	5.51	2.09
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	90.96	14.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	33.32	4.76	2.04	2.72
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	88.21	12.86	3.68	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	37.25	4.19	1.67	3.77
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	56.48	4.65	3.02	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	42.97	6.49	4.05	2.16
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	50.67	6.52	2.52	2.31
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	33.40	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	46.16	7.45	7.45	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	42.22	6.23	4.87	2.71
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	38.76	5.67	2.95	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	38.70	6.70	1.96	3.10
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	47.39	6.01	4.37	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	48.80	6.90	3.71	2.65
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	40.82	4.20	3.00	4.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	72.53	10.17	10.50	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	33.34	5.53	2.93	3.90
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	56.27	5.64	2.65	2.29
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	26.02	6.33	2.11	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	37.70	0.92	1.38	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	50.77	7.71	2.57	2.25
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	82.77	10.35	11.38	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	121.37	27.81	22.76	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	45.23	8.24	2.67	4.23
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	35.99	2.96	1.69	2.12
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	35.13	3.32	3.56	2.61
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	41.21	8.58	3.00	3.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	90.28	18.06	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	37.32	8.00	1.67	2.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	47.79	3.16	3.16	1.80
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	39.28	2.78	2.38	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	43.65	5.57	3.71	3.71
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	49.19	5.30	6.05	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	39.43	5.54	3.58	2.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	24.84	4.36	1.74	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	52.92	7.24	2.71	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	41.45	5.29	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	35.90	7.98	3.32	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	38.69	5.46	2.98	3.97
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	35.60	4.98	0.77	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	32.06	3.93	1.81	1.51
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	54.81	4.64	3.76	1.99
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	44.05	6.10	3.39	3.39
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	81.75	10.22	15.33	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	48.77	5.49	1.22	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	37.14	4.41	2.83	3.15
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	28.15	4.84	1.21	3.33
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	35.60	3.96	1.58	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	90.69	17.00	7.94	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	10.12	5.06	0.00
Myoblast, donor1	11241-116D8	109.07	6.46	2.73	2.24
Myoblast, donor2	11322-117D8	61.56	8.25	2.11	2.69
Myoblast, donor3	11398-118D3	97.37	8.41	2.86	2.86
NK T cell leukemia cell line:KHYG-1	10777-110G3	93.25	7.15	2.63	1.31
Natural Killer Cells, donor1	11230-116C6	107.94	5.54	0.92	1.85
Natural Killer Cells, donor2	11311-117C6	98.61	7.84	0.60	1.21
Natural Killer Cells, donor3	11387-118C1	83.74	6.99	0.74	1.47
Neural stem cells, donor1	11275-116H6	100.53	13.07	9.44	4.36
Neural stem cells, donor2	11352-117H2	82.80	15.41	1.93	1.93
Neurons, donor1	11494-119E9	100.14	18.21	3.41	7.97
Neurons, donor2	11574-120E8	78.16	11.01	4.40	5.72
Neurons, donor3	11655-122E8	91.26	6.58	4.11	2.47
Neutrophils, donor1	11233-116C9	103.94	16.70	1.86	9.28
Neutrophils, donor2	11314-117C9	63.78	17.39	0.00	2.90
Neutrophils, donor3	11390-118C4	116.06	26.88	1.22	15.27
Nucleus Pulposus Cell, donor1	11252-116F1	55.81	10.09	7.48	4.99
Nucleus Pulposus Cell, donor2	11409-118E5	43.31	9.77	3.91	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	51.74	11.03	4.21	1.80
Olfactory epithelial cells, donor1	11933-125I7	60.43	8.12	4.13	2.62
Olfactory epithelial cells, donor2	11934-125I8	78.74	8.11	7.53	3.47
Olfactory epithelial cells, donor3	11935-125I9	71.28	8.17	4.99	2.95
Olfactory epithelial cells, donor4	11936-126A1	75.48	8.18	3.41	2.53
Oligodendrocyte - precursors, donor1	11496-119F2	107.73	11.43	1.20	4.21
Osteoblast - differentiated, donor1	11276-116H7	50.41	5.96	6.38	1.91
Osteoblast - differentiated, donor2	11353-117H3	27.43	9.14	4.57	1.14
Osteoblast - differentiated, donor3	11425-118G3	38.48	8.07	5.59	1.24
Osteoblast, donor1	11277-116H8	70.55	6.06	1.37	1.56
Osteoblast, donor2	11354-117H4	77.96	10.53	2.81	2.81
Osteoblast, donor3	11426-118G4	63.09	7.11	3.02	3.02
Pancreatic stromal cells, donor1	11249-116E7	70.76	7.33	6.82	1.94
Pericytes, donor1	11491-119E6	47.62	6.56	1.56	1.34
Pericytes, donor2	11571-120E5	55.01	4.07	2.04	2.94
Pericytes, donor3	11652-122E5	68.36	7.93	2.85	2.24
Perineurial Cells, donor1	11499-119F5	78.66	11.98	2.49	2.37
Perineurial Cells, donor2	11579-120F4	67.35	6.26	1.75	2.67
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	74.59	7.97	0.64	3.19
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	51.18	7.35	0.24	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	62.77	6.21	0.52	2.20
Placental Epithelial Cells, donor1	11278-116H9	76.53	6.46	1.91	1.67
Placental Epithelial Cells, donor2	11355-117H5	78.73	14.42	2.22	3.33
Placental Epithelial Cells, donor3	11427-118G5	37.50	5.50	1.77	2.16
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	59.81	7.28	3.80	1.27
Preadipocyte - breast, donor1	11467-119B9	84.41	9.00	5.25	2.81
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	59.00	5.61	1.96	2.22
Preadipocyte - breast, donor2	11328-117E5	77.23	7.88	4.28	1.35
Preadipocyte - omental, donor1	11468-119C1	88.12	7.35	5.75	2.45
Preadipocyte - omental, donor2	11329-117E6	87.29	7.42	2.62	3.93
Preadipocyte - omental, donor3	11403-118D8	89.39	9.31	4.30	1.58
Preadipocyte - perirenal, donor1	11469-119C2	50.20	7.87	1.97	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	86.91	6.76	2.15	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	108.37	11.16	2.66	3.19
Preadipocyte - subcutaneous, donor3	11428-118G6	82.93	8.51	2.72	1.53
Preadipocyte - visceral, donor1	11280-116I2	105.07	9.69	3.17	2.24
Preadipocyte - visceral, donor2	11357-117H7	106.76	12.42	4.14	4.14
Preadipocyte - visceral, donor3	11429-118G7	90.18	7.11	1.99	1.36
Prostate Epithelial Cells (polarized), donor1	11253-116F2	64.26	4.37	6.03	1.51
Prostate Epithelial Cells, donor2	11331-117E8	79.35	10.02	2.03	2.57
Prostate Epithelial Cells, donor3	11404-118D9	60.32	14.27	1.59	7.04
Prostate Stromal Cells, donor1	11254-116F3	102.74	8.43	4.67	2.39
Prostate Stromal Cells, donor2	11332-117E9	99.51	9.68	3.77	3.94
Prostate Stromal Cells, donor3	11405-118E1	65.90	9.07	4.69	3.23
Renal Cortical Epithelial Cells, donor1	11516-119H4	67.16	12.41	2.19	1.82
Renal Cortical Epithelial Cells, donor2	11596-120H3	70.49	9.98	1.04	2.77
Renal Epithelial Cells, donor1	11517-119H5	57.82	10.65	0.51	4.06
Renal Epithelial Cells, donor2	11597-120H4	54.77	11.38	0.71	1.42
Renal Epithelial Cells, donor3	11678-122H4	69.13	9.74	1.59	3.07
Renal Glomerular Endothelial Cells, donor1	11514-119H2	54.47	8.17	0.68	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	77.89	8.36	1.21	1.89
Renal Glomerular Endothelial Cells, donor3	11675-122H1	76.37	12.65	1.55	2.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	40.59	9.32	0.67	1.33
Renal Mesangial Cells, donor1	11518-119H6	76.37	8.36	1.98	3.74
Renal Mesangial Cells, donor2	11598-120H5	63.33	6.27	1.25	3.76
Renal Mesangial Cells, donor3	11679-122H5	43.28	6.38	0.55	1.39
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	87.77	12.08	2.15	3.22
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	70.84	7.59	0.84	4.22
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	65.57	7.14	0.19	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	65.60	8.56	1.56	2.85
Retinal Pigment Epithelial Cells, donor1	11528-119I7	63.67	5.40	3.13	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	51.46	6.17	1.03	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	42.15	5.77	2.76	2.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	102.77	14.83	2.27	3.88
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	44.67	7.15	2.68	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	76.50	7.15	4.40	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	75.99	6.96	5.22	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	73.20	8.19	1.82	2.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	69.02	7.45	0.89	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	86.67	7.81	2.45	3.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	88.57	9.43	1.36	2.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	78.55	8.16	0.93	3.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	87.37	7.63	2.08	3.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	65.03	7.94	0.55	3.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	75.03	7.56	1.51	2.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	74.18	6.81	1.97	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	69.29	7.46	1.15	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	79.41	8.37	0.86	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	77.00	7.74	0.66	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	71.31	8.79	2.29	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	67.45	7.55	1.02	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	87.00	6.95	2.07	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	69.27	9.02	1.06	3.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	76.12	8.76	1.75	2.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	80.58	8.21	2.10	3.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	70.59	8.33	1.17	2.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	73.72	9.53	1.12	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	77.42	6.84	0.85	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	69.29	8.75	0.73	4.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	73.82	7.97	0.86	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	78.58	7.66	1.75	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	84.44	8.02	1.42	2.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	77.58	7.74	1.39	4.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	79.74	6.78	1.87	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	79.83	8.50	0.83	3.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	80.74	6.86	1.55	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	78.96	9.40	1.25	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	82.90	10.50	2.02	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	73.06	7.15	0.68	4.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	76.93	7.33	1.35	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	89.92	11.52	3.78	3.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	76.13	6.31	0.82	4.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	79.95	8.04	1.64	3.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	65.45	10.57	1.53	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	80.78	6.51	1.63	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	70.64	8.80	1.07	4.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	64.57	5.53	1.38	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	65.48	7.38	1.90	2.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	81.83	6.65	1.21	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	67.43	6.50	2.83	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	75.81	5.59	1.40	3.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	59.84	7.25	2.72	3.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	69.39	8.81	2.57	2.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	82.38	6.70	4.51	3.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	65.71	6.69	3.65	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	64.20	9.95	2.11	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	59.04	6.11	2.26	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	55.12	8.69	3.00	3.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	54.67	7.08	5.08	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	59.98	6.83	1.92	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	45.67	6.01	4.21	3.00
Schwann Cells, donor1	11498-119F4	60.18	7.33	0.75	1.88
Schwann Cells, donor2	11578-120F3	71.45	0.00	0.00	6.80
Schwann Cells, donor3	11659-122F3	72.30	10.52	1.97	2.41
Sebocyte, donor1	11220-116B5	119.96	13.69	2.19	3.29
Sebocyte, donor2	11301-117B5	78.12	7.35	1.38	4.60
Sebocyte, donor3	11378-118B1	64.93	10.92	2.06	4.74
Sertoli Cells, donor1	11255-116F4	104.37	16.57	3.31	3.31
Sertoli Cells, donor2	11333-117F1	56.49	0.00	8.47	5.65
Skeletal Muscle Cells, donor1	11281-116I3	54.90	7.39	4.13	2.99
Skeletal Muscle Cells, donor2	11358-117H8	28.19	3.61	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	56.85	8.36	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	52.31	9.43	0.94	1.41
Skeletal Muscle Cells, donor5	11455-119A6	53.81	7.88	1.04	1.19
Skeletal Muscle Cells, donor6	11459-119B1	68.49	10.77	1.23	2.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	72.58	8.95	4.54	2.90
Skeletal Muscle Satellite Cells, donor2	11321-117D7	59.36	10.84	3.28	2.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	72.13	8.43	1.59	1.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	76.92	9.35	4.21	3.03
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	47.77	4.34	1.45	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	38.53	7.02	1.79	0.69
Skin - palm, donor1	10286-104F7	61.78	8.06	2.69	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	43.82	7.50	1.59	3.17
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	53.16	9.00	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	52.32	7.27	1.95	2.21
Small Airway Epithelial Cells, donor1	11256-116F5	82.99	10.15	2.50	4.31
Small Airway Epithelial Cells, donor2	11334-117F2	64.14	9.00	0.84	4.92
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	65.55	7.61	2.11	3.17
Small Airway Epithelial Cells, donor3	11406-118E2	69.40	12.07	1.57	5.92
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	104.30	16.35	4.94	4.32
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	49.36	6.00	2.45	2.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	81.71	8.82	1.76	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	63.65	4.20	1.33	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	83.48	7.09	1.58	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	98.12	10.04	3.09	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	63.05	9.01	7.01	7.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	90.23	9.05	2.40	2.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	82.23	9.53	5.98	2.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	63.12	6.40	3.58	2.56
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	68.05	4.88	1.95	1.95
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	90.07	9.16	3.54	2.66
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	66.77	7.55	1.28	1.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	72.55	9.27	1.30	2.44
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	63.02	11.57	4.87	3.96
Smooth Muscle Cells - Carotid, donor1	11285-116I7	65.16	6.06	4.04	1.77
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	68.19	7.15	1.91	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	63.56	5.16	3.39	2.95
Smooth Muscle Cells - Colonic, donor2	11320-117D6	60.91	5.38	2.37	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	61.61	8.92	2.62	1.89
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	90.02	7.42	1.70	1.24
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	60.36	4.31	1.08	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	62.76	3.29	2.09	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	57.01	11.27	1.37	2.39
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	54.26	7.46	5.50	2.36
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	79.61	8.15	6.14	3.42
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	103.08	10.01	2.05	2.28
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	71.25	7.25	3.62	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	108.62	9.01	1.59	4.24
Smooth Muscle Cells - Prostate, donor1	11257-116F6	80.69	9.05	7.72	2.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	72.25	8.51	3.63	3.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	37.03	4.82	6.34	1.52
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	91.67	7.99	3.47	2.71
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	47.26	6.00	3.75	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	42.64	15.51	0.00	11.63
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	79.06	6.98	3.26	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	80.78	8.08	4.54	6.06
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	82.74	6.27	4.39	2.19
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	46.02	9.14	1.77	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	84.39	11.58	2.08	3.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	51.85	7.01	5.14	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	85.06	7.05	1.73	2.88
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	64.50	8.67	2.29	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	54.34	7.71	1.32	1.50
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	78.12	10.20	4.19	3.77
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	69.21	6.79	3.35	2.35
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	38.09	9.52	0.95	1.90
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	85.63	6.12	0.98	1.22
Smooth Muscle Cells - Uterine, donor1	11258-116F7	79.76	8.62	9.28	1.99
Smooth Muscle Cells - Uterine, donor3	11466-119B8	54.42	7.90	5.56	2.34
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	55.59	7.58	2.92	1.55
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	67.17	5.55	4.76	2.91
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	78.11	5.21	11.90	3.35
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	104.57	7.19	2.87	2.87
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	80.91	7.38	3.12	2.27
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	105.16	9.45	2.76	3.15
Smooth muscle cells - airway, control, donor1	11966-126D4	56.63	5.33	3.56	2.03
Smooth muscle cells - airway, control, donor2	11967-126D5	49.91	7.59	5.59	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	46.40	3.34	2.93	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	56.84	8.25	4.13	3.21
Synoviocyte, donor1	11291-117A4	96.62	9.93	4.88	3.03
Synoviocyte, donor2	11368-117I9	60.85	9.55	8.38	1.34
Synoviocyte, donor3	11440-118H9	46.69	6.70	4.47	2.01
Trabecular Meshwork Cells, donor1	11532-120A2	93.98	6.43	0.71	2.50
Trabecular Meshwork Cells, donor2	11612-122A1	65.41	7.93	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	48.39	8.10	1.16	2.32
Tracheal Epithelial Cells, donor1	11292-117A5	48.32	8.32	1.00	3.08
Tracheal Epithelial Cells, donor2	11369-118A1	41.75	10.82	0.77	2.71
Tracheal Epithelial Cells, donor3	11441-118I1	41.23	2.29	0.00	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	98.91	14.39	2.95	4.18
Urethra, donor2	10319-105A4	34.17	14.39	5.40	1.80
Urothelial Cells, donor1	11520-119H8	69.87	11.16	0.80	1.59
Urothelial Cells, donor2	11600-120H7	53.28	8.01	0.00	2.00
Urothelial Cells, donor3	11681-122H7	50.65	8.48	1.15	2.29
Urothelial cells, donor0	11216-116B1	74.89	10.48	1.34	3.57
Whole blood (ribopure), donor090309, donation1	12179-129A1	82.75	9.79	0.89	5.34
Whole blood (ribopure), donor090309, donation2	12180-129A2	64.33	21.44	1.43	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	39.02	13.01	0.68	7.53
Whole blood (ribopure), donor090325, donation1	12176-128I7	55.44	8.26	0.34	3.44
Whole blood (ribopure), donor090325, donation2	12177-128I8	55.78	10.46	0.58	3.49
Whole blood (ribopure), donor090612, donation1	12182-129A4	56.23	19.78	2.08	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	59.66	16.52	0.92	4.59
Whole blood (ribopure), donor090612, donation3	12184-129A6	45.64	14.61	0.91	3.65
Wilms' tumor cell line:G-401	10809-111A8	71.30	6.66	3.45	1.85
Wilms' tumor cell line:HFWT	10597-108E3	41.36	7.04	4.40	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	82.12	11.17	3.91	4.75
achilles tendon, donor2	10292-104G4	59.93	20.67	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	86.43	7.39	0.25	2.29
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	114.69	5.80	6.50	2.32
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	121.68	8.19	0.47	1.78
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	205.45	9.80	0.82	2.72
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	95.57	10.68	0.84	2.53
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	86.50	7.40	3.81	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	86.02	10.89	5.44	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	101.79	4.41	1.76	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	80.45	9.80	2.86	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	86.59	6.99	3.49	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	79.49	10.49	0.92	3.68
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	3.90	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	90.86	8.83	2.79	2.09
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	133.08	14.76	2.33	3.62
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	116.90	17.24	1.17	2.05
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	72.50	5.11	3.25	2.32
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	95.00	11.52	5.35	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	65.38	12.28	0.31	1.53
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	103.26	11.52	3.41	3.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	100.09	14.25	7.58	3.64
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	112.17	13.48	8.42	3.85
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	75.51	8.69	0.45	2.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	67.71	9.34	0.67	2.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	65.04	5.57	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	77.22	9.04	1.88	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	75.45	11.78	3.49	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	80.60	5.62	7.50	1.87
adenocarcinoma cell line:IM95m	10796-110I4	49.69	7.06	7.77	2.35
adipose tissue, adult, pool1	10010-101C1	55.22	7.45	3.57	2.17
adipose, donor1	10184-103D4	80.92	8.80	20.52	1.76
adipose, donor2	10185-103D5	26.76	6.49	4.87	1.62
adipose, donor3	10186-103D6	34.31	12.25	4.90	2.45
adipose, donor4	10187-103D7	61.54	47.67	5.20	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	75.91	35.51	7.26	19.25
adrenal gland, adult, pool1	10081-102A9	14.55	3.64	7.28	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	118.60	11.34	2.53	4.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	57.88	5.72	2.14	1.43
amniotic membrane cells, donor1	12235-129G3	67.24	6.26	4.64	6.72
amniotic membrane cells, donor2	12236-129G4	56.46	12.17	3.72	2.37
amniotic membrane cells, donor3	12237-129G5	22.68	7.07	5.01	4.71
amygdala - adult, donor10196	10167-103B5	55.73	21.34	5.93	4.74
amygdala, adult, donor10252	10151-102I7	60.22	14.80	4.06	5.27
amygdala, newborn, donor10223	10360-105E9	67.14	7.75	2.90	6.78
anaplastic carcinoma cell line:8305C	10428-106D5	70.92	6.62	9.93	2.29
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	138.99	15.44	0.88	2.65
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	50.11	8.35	12.36	1.67
aorta, adult, pool1	10052-101G7	39.62	9.81	1.37	3.33
appendix, adult	10189-103D9	70.25	7.37	1.94	4.66
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	26.48	3.10	2.41	2.06
artery, adult	10190-103E1	65.22	13.59	2.72	8.15
astrocytoma cell line:TM-31	10425-106D2	136.75	18.25	5.22	5.22
b cell line:RPMI1788	10427-106D4	64.54	7.14	5.80	2.68
basal cell carcinoma cell line:TE 354.T	10702-109G9	107.09	7.21	5.27	2.50
bile duct carcinoma cell line:HuCCT1	10432-106D9	83.85	8.34	2.88	3.37
bile duct carcinoma cell line:TFK-1	10496-107C1	35.48	5.02	2.68	3.18
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	54.81	8.95	1.12	1.68
bladder, adult, pool1	10011-101C2	44.00	9.34	4.78	3.59
blood, adult, pool1	10053-101G8	48.72	6.64	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	113.04	5.99	3.43	0.00
bone marrow, adult	10192-103E3	90.43	10.12	4.72	2.02
brain, adult, donor1	10084-102B3	24.60	8.20	6.15	5.13
brain, adult, pool1	10012-101C3	44.10	10.13	8.24	4.12
brain, fetal, pool1	10085-102B4	40.07	16.03	2.67	8.01
breast carcinoma cell line:MCF7	10482-107A5	66.07	11.89	11.56	5.95
breast carcinoma cell line:MDA-MB-453	10419-106C5	117.21	15.73	15.73	3.99
breast, adult, donor1	10080-102A8	58.08	12.00	0.63	3.16
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	22.61	8.26	3.05	3.30
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	75.14	14.22	8.97	6.18
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	37.30	10.13	2.53	5.30
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	59.80	8.47	5.81	3.39
carcinoid cell line:NCI-H1770	10703-109H1	91.68	11.75	1.41	4.23
carcinoid cell line:NCI-H727	10735-110B6	140.88	14.22	4.59	6.45
carcinoid cell line:SK-PN-DW	10719-109I8	100.46	9.82	0.95	3.17
carcinosarcoma cell line:JHUCS-1	10642-109A3	85.71	8.25	7.19	2.40
caudate nucleus - adult, donor10196	10177-103C6	49.51	10.36	6.91	3.45
caudate nucleus, adult, donor10252	10164-103B2	50.87	10.21	7.03	3.51
caudate nucleus, adult, donor10258	10379-105H1	54.25	11.46	9.17	5.35
caudate nucleus, newborn, donor10223	10354-105E3	74.71	6.96	3.30	3.30
cerebellum - adult, donor10196	10173-103C2	96.14	20.39	2.91	8.74
cerebellum, adult, donor10252	10166-103B4	52.95	19.43	0.85	4.91
cerebellum, adult, pool1	10083-102B2	31.05	11.04	3.79	5.17
cerebellum, newborn, donor10223	10357-105E6	54.80	10.79	5.81	5.81
cerebral meninges, adult	10188-103D8	36.06	11.09	5.55	3.78
cerebrospinal fluid, donor2	10294-104G6	48.24	14.62	1.46	4.39
cervical cancer cell line:D98-AH2	10552-107I3	76.64	10.06	14.67	5.61
cervical cancer cell line:ME-180	10553-107I4	154.94	12.59	12.26	3.65
cervix, adult, pool1	10013-101C4	46.09	9.66	6.82	3.88
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	224.61	26.20	15.61	9.89
chondrosarcoma cell line:SW 1353	10700-109G7	36.58	6.53	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	70.71	7.58	3.23	3.85
choriocarcinoma cell line:SCH	10785-110H2	59.88	9.49	2.59	4.56
choriocarcinoma cell line:T3M-3	10618-108G6	53.13	12.57	0.71	7.59
chorionic membrane cells, donor1	12238-129G6	99.72	10.83	1.99	4.27
chorionic membrane cells, donor2	12239-129G7	92.37	10.24	1.69	2.29
chorionic membrane cells, donor3	12240-129G8	151.11	12.64	1.10	3.30
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	121.18	4.04	3.03	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	61.66	10.95	2.50	2.31
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	56.81	9.71	6.34	2.75
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	68.05	14.89	4.62	5.14
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	78.85	12.82	4.35	4.35
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	87.96	12.83	2.24	4.89
chronic myelogenous leukemia cell line:K562	10454-106G4	95.99	10.89	5.30	4.12
chronic myelogenous leukemia cell line:KU812	10409-106B4	71.93	8.34	3.91	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	79.55	18.29	9.14	8.69
clear cell carcinoma cell line:TEN	10636-108I6	58.12	6.59	7.81	3.47
colon carcinoma cell line:CACO-2	10513-107D9	80.36	9.70	4.76	1.65
colon carcinoma cell line:COLO-320	10420-106C6	111.36	14.44	3.04	7.98
colon, adult, donor1	10082-102B1	58.31	8.33	4.76	2.38
colon, adult, pool1	10014-101C5	56.64	9.17	3.64	3.88
colon, fetal, donor1	10070-101I7	27.81	11.74	4.94	2.47
common myeloid progenitor CMP, donor1	12130-128D6	96.25	18.33	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	87.11	3.40	1.70	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	123.61	8.60	0.60	3.17
cord blood derived cell line:COBL-a untreated	10449-106F8	126.91	10.15	0.71	3.38
corpus callosum, adult, pool1	10042-101F6	66.56	16.14	8.96	9.51
cruciate ligament, donor2	10295-104G7	54.30	12.16	0.81	5.67
diaphragm, fetal, donor1	10069-101I6	57.78	9.63	4.01	3.21
diencephalon, adult	10193-103E4	51.60	17.04	6.96	7.68
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	147.41	12.40	2.53	1.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	131.04	17.69	4.36	7.18
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	99.66	6.26	3.61	4.09
ductus deferens, adult	10196-103E7	43.36	12.96	3.49	5.48
duodenum, fetal, donor1, tech_rep1	10071-101I8	50.41	7.20	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	52.23	9.56	5.15	1.47
dura mater, adult, donor1	10041-101F5	72.26	7.76	6.44	4.29
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	101.04	2.44	1.78	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	105.61	8.88	0.43	1.86
embryonic pancreas cell line:1B2C6	10604-108F1	38.85	8.02	1.23	2.47
embryonic pancreas cell line:1C3D3	10605-108F2	28.15	6.36	2.42	3.03
embryonic pancreas cell line:1C3IKEI	10606-108F3	47.86	6.48	2.78	4.01
embryonic pancreas cell line:2C6	10603-108E9	45.97	5.25	1.31	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	80.45	9.05	2.01	3.69
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	79.56	15.04	2.72	9.06
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	72.04	6.75	0.80	2.73
epidermoid carcinoma cell line:A431	10426-106D3	93.82	11.56	9.23	4.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	125.60	13.53	9.13	5.83
epididymis, adult	10197-103E8	52.54	9.42	1.88	5.23
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	98.29	12.24	2.48	3.55
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	49.55	6.29	0.00	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	140.22	15.73	10.88	4.19
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	134.64	12.79	12.40	4.53
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	134.66	15.46	8.74	4.71
esophagus, adult, pool1	10015-101C6	60.84	14.02	3.19	4.35
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	62.49	9.64	1.63	2.50
eye - muscle inferior rectus, donor1	10272-104E2	53.12	24.15	2.41	7.24
eye - muscle lateral, donor2	10298-104H1	52.61	14.73	2.10	8.42
eye - muscle medial, donor2	10299-104H2	17.86	16.37	0.00	8.93
eye - muscle superior, donor2	10297-104G9	24.08	9.17	1.15	5.73
eye - vitreous humor, donor1	10268-104D7	32.06	10.20	0.00	2.91
eye, fetal, donor1	10054-101G9	39.91	9.92	7.12	5.85
fibrosarcoma cell line:HT-1080	10758-110E2	41.93	8.08	1.15	2.18
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	54.13	5.70	1.42	1.66
frontal lobe, adult, pool1	10040-101F4	52.07	11.17	8.82	6.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	127.31	16.51	5.10	7.21
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	46.72	11.06	5.12	4.94
gall bladder, adult	10198-103E9	38.87	9.17	2.66	4.35
gamma delta positive T cells, donor1	11937-126A2	68.18	8.59	0.54	3.22
gamma delta positive T cells, donor2	11938-126A3	66.85	7.84	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	95.47	10.56	5.07	1.90
gastric adenocarcinoma cell line:MKN45	10612-108F9	59.57	14.51	2.71	4.45
gastric cancer cell line:AZ521	10549-107H9	92.14	12.30	2.46	6.39
gastric cancer cell line:GSS	10560-108A2	93.35	12.81	2.75	6.41
gastrointestinal carcinoma cell line:ECC12	10615-108G3	55.52	5.03	1.37	1.37
giant cell carcinoma cell line:LU65	10487-107B1	111.18	20.88	8.95	9.06
giant cell carcinoma cell line:Lu99B	10433-106E1	40.03	4.34	0.28	1.26
glassy cell carcinoma cell line:HOKUG	10688-109F4	79.31	10.23	2.00	5.74
glioblastoma cell line:A172, tech_rep1	10444-106F3	56.47	3.91	2.85	1.06
glioblastoma cell line:A172, tech_rep2	10444-106F3	56.74	6.74	1.40	0.98
glioblastoma cell line:T98G	10485-107A8	105.52	9.60	10.26	2.32
glioma cell line:GI-1	10413-106B8	52.13	5.86	5.56	3.22
globus pallidus - adult, donor10196	10175-103C4	53.21	13.12	3.64	10.93
globus pallidus, adult, donor10252	10161-103A8	69.08	18.55	3.42	6.59
globus pallidus, adult, donor10258	10367-105F7	26.01	8.22	8.22	6.85
globus pallidus, newborn, donor10223	10364-105F4	45.30	6.40	4.80	4.80
granulocyte macrophage progenitor, donor1	12131-128D7	124.80	9.79	2.45	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	62.72	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	71.04	5.44	1.92	2.56
hIPS +CCl2, biol_rep1	14383-156B9	110.65	23.87	12.40	1.84
hIPS +CCl2, biol_rep2	14384-156C1	117.06	22.41	5.94	4.12
hIPS +CCl2, biol_rep3	14385-156C2	104.34	21.26	12.24	5.15
hIPS, biol_rep1	14380-156B6	27.31	24.43	1.44	0.00
hIPS, biol_rep2	14381-156B7	97.39	15.77	8.23	0.69
hIPS, biol_rep3	14382-156B8	62.90	14.35	0.00	5.52
hairy cell leukemia cell line:Mo	10712-109I1	101.43	6.90	0.57	0.86
heart - mitral valve, adult	10205-103F7	55.01	10.16	3.89	2.69
heart - pulmonic valve, adult	10206-103F8	63.80	10.98	3.40	4.45
heart - tricuspid valve, adult	10207-103F9	35.80	9.99	2.50	5.83
heart, adult, diseased post-infarction, donor1	10050-101G5	71.83	10.81	2.24	6.73
heart, adult, diseased, donor1	10051-101G6	85.59	15.33	4.26	5.54
heart, adult, pool1	10016-101C7	98.20	14.03	5.29	5.29
heart, fetal, pool1	10046-101G1	102.99	14.07	13.25	2.88
hepatic mesenchymal tumor cell line:LI90	10778-110G4	86.08	10.18	3.09	2.47
hepatoblastoma cell line:HuH-6	10633-108I3	30.92	5.95	0.00	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	61.99	6.96	3.54	2.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	63.48	4.98	4.25	1.58
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	62.35	6.06	6.37	1.11
hepatoma cell line:Li-7	10484-107A7	108.77	6.67	3.11	1.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	80.90	6.93	1.01	1.61
hippocampus - adult, donor10196	10169-103B7	38.80	15.14	6.62	4.73
hippocampus, adult, donor10252	10153-102I9	55.92	12.45	3.47	7.96
hippocampus, adult, donor10258	10374-105G5	32.37	8.96	3.98	1.00
hippocampus, newborn, donor10223	10363-105F3	34.54	7.40	4.58	4.58
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	83.62	12.21	3.66	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	60.48	8.44	0.98	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	62.71	6.60	3.05	2.79
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	43.42	5.64	6.20	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	50.87	8.00	8.78	3.87
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	62.64	7.97	7.21	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	37.08	4.96	9.05	2.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	34.68	5.82	9.69	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	38.37	4.17	6.26	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	57.30	4.03	6.16	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	48.86	7.23	8.52	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	57.90	4.71	4.71	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	58.06	7.51	2.19	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	74.19	9.33	3.44	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	68.07	7.85	3.49	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	58.42	7.83	10.69	2.86
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	55.38	7.85	7.41	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	56.97	6.50	12.49	3.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	29.95	5.46	8.85	3.96
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	31.38	9.09	9.55	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	29.76	5.64	8.46	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	53.40	8.82	7.51	3.27
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	53.42	6.97	5.81	4.06
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	55.90	6.88	5.38	3.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	63.18	9.05	2.77	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	61.91	11.98	2.85	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	83.70	7.76	4.08	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	53.87	8.80	5.99	2.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	54.80	6.33	3.17	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	57.50	6.66	4.54	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	33.61	4.65	7.24	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	29.89	3.98	5.31	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	27.96	4.87	6.16	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	57.27	3.07	3.32	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	46.19	5.30	4.54	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	49.40	3.36	3.36	3.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	66.90	8.21	4.35	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	60.61	6.24	2.67	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	62.93	7.80	4.39	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	55.62	6.42	6.11	3.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	149.65	6.51	42.29	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	58.91	8.60	9.60	3.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	32.29	6.02	7.11	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	30.76	6.15	8.32	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	27.76	4.98	10.68	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	47.74	5.97	3.58	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	54.98	5.82	7.72	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	47.95	5.12	5.12	1.35
immature langerhans cells, donor1	11904-125F5	133.66	14.04	2.66	3.15
immature langerhans cells, donor2	11905-125F6	88.72	15.05	1.58	1.58
insula, adult, pool1	10039-101F3	58.20	11.83	6.62	4.92
keratoacanthoma cell line:HKA-1	10791-110H8	68.61	9.43	10.40	3.25
kidney, adult, pool1	10017-101C8	79.10	13.92	2.00	3.90
kidney, fetal, pool1	10045-101F9	66.49	10.47	3.61	3.68
large cell lung carcinoma cell line:IA-LM	10509-107D5	78.82	8.52	7.53	4.54
large cell lung carcinoma cell line:NCI-H460	10839-111E2	58.61	7.60	9.54	3.18
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	94.50	7.71	4.77	4.59
left atrium, adult, donor1	10079-102A7	40.32	10.90	2.18	7.08
left ventricle, adult, donor1	10078-102A6	52.59	12.64	4.05	4.05
leiomyoblastoma cell line:G-402	10721-110A1	65.67	6.84	1.92	2.46
leiomyoma cell line:10964C	10569-108B2	76.16	9.70	3.95	2.16
leiomyoma cell line:15242A	10570-108B3	64.67	5.98	6.52	2.72
leiomyoma cell line:15425	10571-108B4	83.04	11.41	7.04	2.19
leiomyosarcoma cell line:Hs 5.T	10722-110A2	76.19	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	136.97	14.64	4.18	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	83.70	7.79	2.24	1.42
liposarcoma cell line:KMLS-1	10782-110G8	60.77	6.56	2.19	1.56
liposarcoma cell line:SW 872	10726-110A6	88.33	10.48	4.51	2.44
liver, adult, pool1	10018-101C9	51.70	7.29	0.97	2.27
liver, fetal, pool1	10086-102B5	33.87	7.53	0.00	5.64
locus coeruleus - adult, donor10196	10182-103D2	47.39	11.81	3.50	8.17
locus coeruleus, adult, donor10252	10165-103B3	52.97	13.47	4.61	6.27
locus coeruleus, adult, donor10258	10375-105G6	36.96	7.90	3.67	4.51
locus coeruleus, newborn, donor10223	10362-105F2	79.08	11.36	5.89	6.73
lung adenocarcinoma cell line:A549	10499-107C4	74.87	9.83	2.77	5.26
lung adenocarcinoma cell line:PC-14	10408-106B3	119.96	11.72	9.65	4.14
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	76.45	19.51	2.50	7.38
lung, adult, pool1	10019-101D1	62.14	9.33	2.24	2.84
lung, fetal, donor1	10068-101I5	87.62	16.84	11.13	7.14
lung, right lower lobe, adult, donor1	10075-102A3	44.91	10.54	2.29	10.08
lymph node, adult, donor1	10077-102A5	41.18	3.79	1.42	3.31
lymphangiectasia cell line:DS-1	10727-110A7	114.85	12.27	3.07	5.04
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	156.36	8.30	3.92	1.81
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	91.75	11.04	2.55	3.40
mature adipocyte, donor1	12231-129F8	61.27	8.44	3.55	4.00
mature adipocyte, donor2	12232-129F9	80.31	12.04	2.91	4.15
mature adipocyte, donor3	12233-129G1	77.52	12.33	6.40	4.27
mature adipocyte, donor4	12234-129G2	80.54	12.63	7.63	2.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	100.07	22.16	8.82	12.15
medial frontal gyrus - adult, donor10196	10170-103B8	34.97	12.41	3.38	6.77
medial frontal gyrus, adult, donor10252	10150-102I6	41.75	11.59	3.31	5.33
medial frontal gyrus, adult, donor10258	10368-105F8	36.53	7.62	5.72	3.49
medial frontal gyrus, newborn, donor10223	10352-105E1	73.78	13.22	9.81	2.99
medial temporal gyrus - adult, donor10196	10183-103D3	49.95	9.11	6.58	3.21
medial temporal gyrus, adult, donor10252	10156-103A3	50.30	14.86	2.97	5.52
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	13.48	1.93	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	14.35	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	67.48	9.33	6.10	3.95
medulla oblongata - adult, donor10196	10174-103C3	48.67	8.44	5.19	3.24
medulla oblongata, adult, donor10252	10155-103A2	62.39	16.10	2.17	6.35
medulla oblongata, adult, pool1	10038-101F2	59.26	12.65	7.43	6.29
medulla oblongata, newborn, donor10223	10361-105F1	57.98	11.11	4.51	3.82
medulloblastoma cell line:D283 Med	10838-111E1	47.38	4.87	0.66	3.54
medulloblastoma cell line:ONS-76	10759-110E3	62.24	8.80	1.59	3.67
melanoma cell line:COLO 679	10514-107E1	32.49	4.46	1.58	2.16
melanoma cell line:G-361	10465-106H6	49.13	8.42	2.17	3.53
meningioma cell line:HKBMM	10691-109F7	78.69	15.20	1.63	5.43
merkel cell carcinoma cell line:MKL-1	10843-111E6	65.21	7.93	5.29	5.29
merkel cell carcinoma cell line:MS-1	10844-111E7	61.70	8.04	0.00	2.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	77.79	8.13	2.92	2.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	57.44	7.27	3.45	2.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	78.27	7.45	4.14	2.48
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	61.53	7.02	4.07	2.11
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	54.30	5.78	2.50	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	72.18	9.02	6.25	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	69.34	9.95	4.98	2.75
mesenchymal precursor cell - cardiac, donor2	11753-123G7	59.35	5.98	4.83	1.38
mesenchymal precursor cell - cardiac, donor3	11754-123G8	77.86	11.27	2.65	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	81.56	8.78	3.11	1.62
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	83.79	7.26	1.42	2.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	61.92	7.25	2.31	3.62
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	71.81	7.89	3.18	1.80
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	89.71	8.73	3.49	3.14
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	78.60	9.80	5.10	1.84
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	64.70	8.99	3.59	1.80
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	55.86	6.00	1.97	2.48
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	78.20	5.47	2.05	2.28
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	124.61	10.07	8.39	3.78
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	66.65	8.67	3.44	1.94
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	71.78	9.45	2.54	1.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	51.54	5.89	2.95	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	63.53	7.15	2.00	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	114.09	9.68	4.21	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	53.89	8.68	4.11	2.74
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	64.97	6.39	6.14	2.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	73.55	8.64	4.71	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	75.48	8.63	2.77	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	65.90	8.71	3.06	2.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	73.11	8.12	6.09	2.03
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	61.30	7.07	4.32	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	70.90	4.17	1.85	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	96.61	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	75.28	8.36	4.33	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	74.29	8.70	3.79	2.90
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	69.22	10.82	3.36	3.85
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	74.80	9.53	2.93	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	59.41	8.39	4.03	2.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	64.68	7.78	4.50	2.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	69.59	5.58	4.30	2.58
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	46.48	2.73	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	67.14	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	60.73	3.90	3.57	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	48.01	2.91	2.91	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	47.98	8.53	5.33	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	49.07	3.27	3.27	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	47.81	7.39	5.05	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	44.07	6.30	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	35.76	3.97	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	0.00	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	54.55	4.74	3.56	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	49.96	8.53	4.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	54.47	8.23	3.80	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	48.98	5.86	6.90	2.76
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	38.69	8.60	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	47.90	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	55.10	3.44	10.33	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	43.60	5.30	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	47.67	2.38	3.97	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	43.62	5.90	3.54	3.54
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	41.77	5.30	2.81	2.81
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	46.78	4.01	1.34	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	46.12	5.91	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	51.36	0.00	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	50.25	6.20	2.07	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	106.38	7.42	2.47	3.96
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	87.48	5.61	3.36	5.61
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	113.22	8.27	2.54	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	120.49	13.70	3.63	3.63
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	135.20	15.26	6.54	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	111.50	10.14	1.27	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	91.64	10.92	4.86	4.25
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	94.90	27.11	13.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	82.37	15.65	4.12	6.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	50.80	6.75	3.97	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	49.00	7.79	6.49	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	50.93	9.17	5.09	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	83.56	5.42	3.09	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	140.09	18.90	1.42	13.70
mesothelioma cell line:ACC-MESO-4	10494-107B8	85.49	8.11	8.80	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	141.03	8.55	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	155.26	11.30	3.49	1.95
mesothelioma cell line:Mero-25	10850-111F4	123.24	7.72	2.50	1.59
mesothelioma cell line:Mero-41	10851-111F5	132.26	17.36	3.18	6.85
mesothelioma cell line:Mero-48a	10852-111F6	114.92	11.96	4.65	2.44
mesothelioma cell line:Mero-82	10853-111F7	59.13	4.20	3.94	1.31
mesothelioma cell line:Mero-83	10854-111F8	111.32	8.34	1.19	2.38
mesothelioma cell line:Mero-84	10855-111F9	87.46	6.57	1.77	2.02
mesothelioma cell line:Mero-95	10856-111G1	56.11	7.25	3.31	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	78.52	8.12	1.66	2.82
mesothelioma cell line:NCI-H226	10846-111E9	106.79	8.87	5.43	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	80.97	10.93	4.27	2.90
mesothelioma cell line:NCI-H28	10845-111E8	75.07	7.89	6.62	2.04
mesothelioma cell line:No36	10857-111G2	127.87	6.85	2.94	3.91
mesothelioma cell line:ONE58	10858-111G3	147.94	12.46	2.17	4.06
migratory langerhans cells, donor1	11901-125F2	172.73	14.01	0.58	2.49
migratory langerhans cells, donor2	11902-125F3	107.22	9.28	0.49	2.08
migratory langerhans cells, donor3	11903-125F4	119.00	11.67	2.33	3.05
mixed mullerian tumor cell line:HTMMT	10689-109F5	93.05	9.47	1.96	2.29
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	49.59	8.90	1.91	2.54
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	78.32	12.67	4.84	8.29
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	62.61	6.85	1.14	3.04
myelodysplastic syndrome cell line:SKM-1	10772-110F7	139.33	17.56	5.17	3.70
myeloma cell line:PCM6	10474-106I6	74.92	9.88	2.17	5.14
myxofibrosarcoma cell line:MFH-ino	10600-108E6	89.28	21.81	6.09	4.57
myxofibrosarcoma cell line:NMFH-1	10684-109E9	84.54	12.36	4.71	3.73
nasal epithelial cells, donor1, tech_rep1	12226-129F3	53.37	11.81	1.34	5.79
nasal epithelial cells, donor1, tech_rep2	12226-129F3	54.64	11.55	1.18	5.96
nasal epithelial cells, donor2	12227-129F4	59.06	17.66	1.66	4.97
neuroblastoma cell line:CHP-134	10508-107D4	57.29	5.52	3.91	2.76
neuroblastoma cell line:NB-1	10539-107G8	112.63	14.78	8.98	4.86
neuroblastoma cell line:NBsusSR	10607-108F4	85.20	15.82	2.11	4.01
neuroblastoma cell line:NH-12	10555-107I6	43.42	7.45	4.66	2.80
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	85.64	6.41	3.32	2.14
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	62.09	6.65	1.11	2.06
neuroectodermal tumor cell line:TASK1	10774-110F9	82.32	10.26	1.81	1.41
neuroepithelioma cell line:SK-N-MC	10728-110A8	111.89	10.17	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	75.59	10.65	1.86	2.66
neutrophil PMN, donor1	12133-128D9	208.25	29.75	0.00	14.87
neutrophil PMN, donor2	12137-128E4	92.96	13.28	0.00	13.28
neutrophil PMN, donor3	12141-128E8	56.82	18.94	9.47	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	124.64	9.30	9.98	2.37
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	67.24	12.81	1.60	7.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	54.18	5.13	10.26	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	75.15	6.57	4.20	2.10
nucleus accumbens, adult, pool1	10037-101F1	57.27	13.31	7.03	6.56
occipital cortex - adult, donor10196	10172-103C1	51.51	12.36	4.12	4.12
occipital cortex, adult, donor10252	10163-103B1	45.62	11.54	1.07	6.98
occipital cortex, newborn, donor10223	10355-105E4	40.03	17.83	3.64	5.82
occipital lobe, adult, donor1	10076-102A4	40.93	13.91	4.20	7.08
occipital lobe, fetal, donor1	10073-102A1	52.78	15.45	5.58	7.72
occipital pole, adult, pool1	10036-101E9	47.54	10.49	4.57	4.65
olfactory region, adult	10195-103E6	37.83	13.18	5.92	4.59
optic nerve, donor1	10277-104E7	30.02	10.01	2.00	10.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	131.22	11.50	16.40	6.72
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	61.82	7.56	4.81	2.20
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	90.59	14.22	2.37	3.39
oral squamous cell carcinoma cell line:SAS	10544-107H4	60.76	7.85	4.97	2.43
osteoclastoma cell line:Hs 706.T	10704-109H2	86.13	10.88	2.35	3.23
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	153.23	4.67	2.80	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	99.03	5.09	3.82	2.12
ovary, adult, pool1	10020-101D2	38.61	6.81	2.53	1.92
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	94.23	11.18	1.10	5.32
pancreas, adult, donor1	10049-101G4	28.22	9.41	2.82	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	116.29	11.18	1.40	6.71
papillary adenocarcinoma cell line:8505C	10437-106E5	112.09	11.24	3.92	3.24
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	105.64	14.74	7.29	7.95
paracentral gyrus, adult, pool1	10035-101E8	51.25	8.69	6.68	5.13
parietal cortex, adult, donor10258	10373-105G4	36.70	14.68	5.87	5.87
parietal lobe - adult, donor10196	10171-103B9	42.32	10.35	2.82	7.52
parietal lobe, adult, donor10252	10157-103A4	42.19	15.11	4.28	6.84
parietal lobe, adult, pool1	10034-101E7	53.40	10.13	7.67	6.26
parietal lobe, fetal, donor1	10072-101I9	58.19	12.61	7.76	4.85
parietal lobe, newborn, donor10223	10356-105E5	63.93	6.36	2.62	2.99
parotid gland, adult	10199-103F1	53.03	12.33	1.85	4.93
penis, adult	10200-103F2	38.67	9.67	7.52	4.83
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	35.33	4.09	0.56	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	87.85	13.55	10.20	4.37
pineal gland - adult, donor10196	10179-103C8	33.54	11.61	3.87	6.45
pineal gland, adult, donor10252	10160-103A7	59.22	17.77	4.15	3.55
pineal gland, adult, donor10258	10377-105G8	38.25	11.91	2.51	5.64
pituitary gland - adult, donor10196	10180-103C9	37.44	12.14	5.06	4.05
pituitary gland, adult, donor10252	10162-103A9	53.68	14.07	3.65	3.65
pituitary gland, adult, donor10258	10378-105G9	29.79	8.51	0.85	2.55
placenta, adult, pool1	10021-101D3	279.08	25.48	2.15	5.59
plasma cell leukemia cell line:ARH-77	10840-111E3	110.97	8.21	3.84	3.05
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	78.13	8.56	4.36	3.11
pons, adult, pool1	10033-101E6	55.43	11.96	6.89	7.40
postcentral gyrus, adult, pool1	10032-101E5	47.95	10.98	4.62	3.75
promyelocytes/myelocytes PMC, donor1	12132-128D8	94.11	20.91	4.18	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	77.11	5.51	11.02	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	58.56	10.20	1.31	5.54
prostate cancer cell line:PC-3	10439-106E7	146.65	14.34	2.72	4.90
prostate, adult, pool1	10022-101D4	42.08	7.44	4.26	3.08
putamen, adult, donor10196	10176-103C5	60.20	15.34	8.26	5.19
putamen, adult, donor10252	10152-102I8	45.10	11.76	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	38.25	13.11	5.46	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	45.42	12.08	5.32	2.90
putamen, newborn, donor10223	10365-105F5	64.47	14.24	11.24	6.75
rectal cancer cell line:TT1TKB	10469-106I1	43.35	4.07	3.20	2.33
rectum, fetal, donor1	10067-101I4	59.81	9.74	6.95	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	69.96	10.81	7.84	7.63
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	36.04	12.84	2.90	4.14
retina, adult, pool1	10030-101E3	56.66	8.05	7.36	5.07
retinoblastoma cell line:Y79	10475-106I7	110.16	10.13	12.73	4.42
rhabdomyosarcoma cell line:KYM-1	10787-110H4	40.82	8.24	0.49	1.97
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	129.35	20.25	0.56	7.59
sacrococcigeal teratoma cell line:HTST	10695-109G2	79.57	7.58	3.03	3.79
salivary acinar cells, donor1	11771-123I7	37.87	8.25	3.08	3.56
salivary acinar cells, donor2	11772-123I8	43.10	5.92	1.24	5.65
salivary acinar cells, donor3	11773-123I9	58.26	7.94	1.99	7.28
salivary gland, adult, pool1	10093-102C3	49.19	16.59	7.44	6.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	76.13	8.18	2.36	3.12
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	69.94	7.29	2.70	3.76
seminal vesicle, adult	10201-103F3	45.50	17.46	2.12	4.23
serous adenocarcinoma cell line:JHOS-2	10639-108I9	61.95	7.77	12.63	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	71.21	8.56	1.26	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	118.42	12.04	2.01	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	53.06	7.25	0.27	2.28
signet ring carcinoma cell line:Kato III	10436-106E4	112.52	9.95	3.43	3.87
signet ring carcinoma cell line:NUGC-4	10483-107A6	54.32	9.68	2.06	2.06
skeletal muscle - soleus muscle, donor1	10282-104F3	91.50	29.79	4.26	11.35
skeletal muscle, adult, pool1	10023-101D5	63.93	15.11	5.76	8.28
skeletal muscle, fetal, donor1	10066-101I3	19.10	8.04	2.01	1.01
skin, adult, donor1	10074-102A2	122.13	6.79	6.79	6.79
skin, fetal, donor1	10065-101I2	49.87	8.21	10.10	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	57.03	10.67	3.34	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	87.00	9.46	3.15	2.21
small cell lung carcinoma cell line:DMS 144	10841-111E4	45.68	17.35	5.78	10.79
small cell lung carcinoma cell line:LK-2	10541-107H1	53.24	6.92	1.48	3.79
small cell lung carcinoma cell line:NCI-H82	10842-111E5	78.33	14.15	1.61	4.83
small cell lung carcinoma cell line:WA-hT	10562-108A4	51.21	9.37	1.09	2.62
small intestine, adult, pool1	10024-101D6	89.46	13.62	2.87	4.18
small intestine, fetal, donor1	10064-101I1	57.25	6.14	6.14	2.21
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	63.09	14.87	3.59	3.59
smooth muscle, adult, pool1	10048-101G3	41.09	8.01	4.39	3.88
somatostatinoma cell line:QGP-1	10781-110G7	36.45	10.45	1.34	7.24
spinal cord - adult, donor10196	10181-103D1	41.06	16.52	4.59	8.95
spinal cord, adult, donor10252	10159-103A6	59.93	15.38	3.94	4.34
spinal cord, adult, donor10258	10369-105F9	50.50	13.84	9.69	4.15
spinal cord, fetal, donor1	10056-101H2	59.76	8.54	7.32	9.76
spinal cord, newborn, donor10223	10359-105E8	79.90	9.64	6.89	5.51
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	96.93	9.71	3.44	3.58
spleen, adult, pool1	10025-101D7	61.57	6.39	1.65	2.97
spleen, fetal, pool1	10044-101F8	68.97	9.14	2.15	3.18
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	67.90	5.80	1.55	3.11
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	72.91	10.82	7.78	4.94
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	69.19	11.53	2.10	4.89
squamous cell carcinoma cell line:T3M-5	10616-108G4	91.48	11.34	6.25	4.30
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	168.95	24.54	20.37	10.36
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	308.81	24.57	2.12	5.51
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	208.57	18.62	5.08	4.23
stomach, fetal, donor1	10062-101H8	33.11	9.61	2.14	5.34
submaxillary gland, adult	10202-103F4	37.03	12.53	3.99	5.70
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	59.20	15.37	2.91	7.06
substantia nigra, adult, donor10258	10371-105G2	44.48	13.45	5.17	3.10
substantia nigra, newborn, donor10223	10358-105E7	40.98	9.19	3.53	5.65
synovial sarcoma cell line:HS-SY-II	10441-106E9	126.33	20.63	7.57	10.55
temporal lobe, adult, pool1	10031-101E4	48.15	11.36	5.26	4.66
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	42.74	19.23	2.85	4.27
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	60.66	21.10	3.52	5.27
tenocyte, donor1	11763-123H8	100.89	9.43	1.75	1.75
tenocyte, donor2	11765-123I1	70.96	10.30	4.96	3.05
tenocyte, donor3	11768-123I4	99.34	10.75	6.30	3.71
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	205.48	22.26	1.36	5.78
teratocarcinoma cell line:NCR-G1	10798-110I6	84.01	7.09	4.47	2.00
teratocarcinoma cell line:PA-1	10807-111A6	75.47	8.83	0.77	1.39
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	72.87	14.09	0.38	5.59
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	112.32	21.93	4.54	8.32
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	64.02	9.82	0.65	2.94
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	118.56	16.29	2.61	2.28
testis, adult, pool1	10026-101D8	46.28	10.95	2.15	3.44
testis, adult, pool2	10096-102C6	62.25	16.69	1.80	3.61
thalamus - adult, donor10196	10168-103B6	50.78	8.83	2.21	5.52
thalamus, adult, donor10252	10154-103A1	51.89	14.85	3.44	8.13
thalamus, adult, donor10258, tech_rep1	10370-105G1	26.17	10.78	4.62	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	26.52	9.06	4.12	3.13
thalamus, newborn, donor10223	10366-105F6	82.85	8.63	1.73	6.33
throat, adult	10209-103G2	63.42	11.48	4.24	2.50
throat, fetal, donor1	10061-101H7	54.54	9.14	7.92	5.48
thymic carcinoma cell line:Ty-82	10803-111A2	96.38	10.14	3.78	0.99
thymus, adult, pool1	10027-101D9	103.29	8.65	2.39	2.78
thymus, fetal, pool1	10043-101F7	121.67	8.52	1.66	2.39
thyroid carcinoma cell line:KHM-5M	10776-110G2	132.16	12.63	3.06	6.12
thyroid carcinoma cell line:TCO-1	10783-110G9	87.87	6.29	8.10	1.26
thyroid, adult, pool1	10028-101E1	63.36	10.73	2.33	2.89
thyroid, fetal, donor1	10060-101H6	51.68	10.55	2.64	6.59
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	9.24	3.08	6.16
tongue, adult	10203-103F5	65.59	12.33	3.49	5.35
tongue, fetal, donor1	10059-101H5	65.81	17.34	4.73	9.85
tonsil, adult, pool1	10047-101G2	94.67	11.52	2.30	2.60
trachea, adult, pool1	10029-101E2	60.20	10.55	2.78	4.09
trachea, fetal, donor1	10058-101H4	46.16	5.77	2.69	3.08
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	92.11	9.21	3.54	3.19
transitional-cell carcinoma cell line:5637	10418-106C4	119.15	13.07	3.34	3.85
transitional-cell carcinoma cell line:JMSU1	10492-107B6	47.79	8.77	2.35	2.98
tridermal teratoma cell line:HGRT	10694-109G1	83.71	1.90	5.71	5.71
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	63.91	8.89	4.49	2.45
umbilical cord, fetal, donor1	10057-101H3	39.64	14.61	8.35	6.26
uterus, adult, pool1	10100-102D1	54.09	11.94	5.46	2.56
uterus, fetal, donor1	10055-101H1	51.70	11.26	8.19	3.58
vagina, adult	10204-103F6	42.00	10.99	1.29	3.88
vein, adult	10191-103E2	56.33	6.36	0.88	2.85
xeroderma pigentosum b cell line:XPL 17	10563-108A5	63.55	7.48	0.80	2.14

Property "Nearest transcripts" (as page type) with input value "AB590387:-165 DQ893386:-165 DQ896706:-165 KJ904582:-165 M74524:-284 ENST00000629303.2:-298 BC010175:-302 ENST00000469205.2:-305 AK223064:-308 AK297696:-311 AK223045:-311 ENST00000371558.7:-313 ENST00000630695.2:-313 ENST00000631185.2:-313 NM_001282161.2:-313 NM_181762.3:-313 NM_003336.4:-313 AK313092:-313 ENST00000625379.1:-327 ENST00000625938.2:-330 D28459:-338 ENST00000346330.6:-340 AK301675:-341" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.